[go: up one dir, main page]

WO2025173750A1 - Blood purification device - Google Patents

Blood purification device

Info

Publication number
WO2025173750A1
WO2025173750A1 PCT/JP2025/004809 JP2025004809W WO2025173750A1 WO 2025173750 A1 WO2025173750 A1 WO 2025173750A1 JP 2025004809 W JP2025004809 W JP 2025004809W WO 2025173750 A1 WO2025173750 A1 WO 2025173750A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood
detection unit
change
characteristic change
detected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/JP2025/004809
Other languages
French (fr)
Japanese (ja)
Inventor
雄貴 片山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nikkiso Co Ltd
Original Assignee
Nikkiso Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikkiso Co Ltd filed Critical Nikkiso Co Ltd
Publication of WO2025173750A1 publication Critical patent/WO2025173750A1/en
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits

Definitions

  • the present invention relates to a blood purification device that detects recirculated blood, which is blood returned to a patient from a venous blood circuit and then guided back into an arterial blood circuit.
  • a patient's blood is circulated extracorporeally through a blood circuit, and purified using a dialyzer.
  • a dialyzer a site where an artery and a vein are connected by surgery
  • blood that has been purified and returned to the patient's body through the venous puncture needle can sometimes become recirculated blood, where the purified blood is introduced back into the blood circuit through the arterial puncture needle without passing through the patient's organs.
  • the purified blood must be further circulated extracorporeally, which reduces the amount of blood that needs to be purified that is circulating extracorporeally, resulting in a problem of reduced blood purification efficiency.
  • a dialysis machine In order to detect such recirculated blood, as disclosed in Patent Document 1, for example, a dialysis machine has been proposed that operates a water removal pump to give a specific peak to the change in concentration of blood circulating extracorporeally, and uses this as a marker to detect blood recirculation.
  • a sensor that detects blood concentration a sensor that detects hemoglobin concentration
  • a sensor that detects hemoglobin concentration is placed in the arterial blood circuit, and blood recirculation during dialysis treatment can be detected by detecting the specific peak with this sensor.
  • the detected local concentration change may vary depending on the patient's condition, the treatment environment, etc., and in order to accurately calculate the proportion of recirculated blood, it is necessary to accurately grasp the start and end points of the local concentration change. Therefore, the present applicant has conducted extensive research to accurately detect at least the start point of the local concentration change in order to accurately calculate the proportion of recirculated blood. Similar issues also exist when calculating the proportion of recirculated blood based on changes in other blood characteristics, such as blood temperature, instead of blood concentration.
  • the blood characteristics are not limited to blood concentration but include general blood characteristics, such as blood temperature.
  • the present invention was made in consideration of these circumstances, and aims to provide a blood purification device that can accurately calculate the proportion of recirculated blood by accurately detecting at least the start or end point of a local characteristic change.
  • One embodiment of the present invention is a blood purification device that circulates a patient's blood extracorporeally through a blood circuit having an arterial blood circuit and a venous blood circuit, and purifies the blood.
  • the blood purification device includes: a characteristic change imparting unit that can impart a local characteristic change with a peak that is specific to the characteristic change of the blood circulating extracorporeally through the blood circuit; a first detection unit and a second detection unit that are attached to the arterial blood circuit and the venous blood circuit, respectively, and detect the local characteristic change imparted by the characteristic change imparting unit; and a recirculation detection unit that detects recirculated blood, which is blood returned to the patient from the venous blood circuit and then guided back into the arterial blood circuit based on the local characteristic change detected by the first detection unit and the local characteristic change detected by the second detection unit, and calculates the proportion of recirculated blood.
  • the recirculation detection unit detects a noise waveform detected immediately before the local characteristic change is detected, and
  • the blood purification device includes a characteristic change imparting unit that can impart a local characteristic change in which a peak specific to the characteristic change of the blood circulating extracorporeally through the blood circuit is formed; a first detection unit and a second detection unit that are attached to the arterial blood circuit and the venous blood circuit, respectively, and detect the local characteristic change imparted by the characteristic change imparting unit; and a recirculation detection unit that detects recirculated blood, which is blood returned to the patient from the venous blood circuit and then guided back into the arterial blood circuit based on the local characteristic change detected by the first detection unit and the local characteristic change detected by the second detection unit, and calculates the proportion of recirculated blood.
  • the recirculation detection unit sequentially searches back to the start of detection of the local characteristic change, using the time when a specific peak in
  • another embodiment of the present invention is a blood purification device that circulates a patient's blood extracorporeally through a blood circuit having an arterial blood circuit and a venous blood circuit, and purifies the blood.
  • the blood purification device includes a characteristic change imparting unit that can impart a local characteristic change in which a peak specific to the characteristic change of the blood circulating extracorporeally through the blood circuit; a first detection unit and a second detection unit that are attached to the arterial blood circuit and the venous blood circuit, respectively, and detect the local characteristic change imparted by the characteristic change imparting unit; and a recirculation detection unit that detects recirculated blood, in which blood returned from the venous blood circuit is guided back into the arterial blood circuit and flows, based on the local characteristic change detected by the first detection unit and the local characteristic change detected by the second detection unit, and calculates the proportion of recirculated blood.
  • the recirculation detection unit detects the amount of change in the local characteristic change over time or with the cumulative blood flow rate after the specific peak is detected, and identifies the point at which the amount of change changes from a decrease to an increase as the end point of the local characteristic change.
  • the proportion of recirculating blood can be calculated with high accuracy by accurately detecting at least the start or end point of a local characteristic change.
  • FIG. 1 is a schematic diagram showing a blood purification device according to an embodiment of the present invention.
  • Block diagram showing the main components of the blood purification device FIG. 1 is a block diagram showing the recirculation detection unit of the blood purification device.
  • a flowchart showing the control performed by the control unit of the blood purification device. 1 is a flowchart showing the control content during the measurement process by the recirculation detection unit of the blood purification device according to the first embodiment of the present invention.
  • Graph illustrating the measurement process by the recirculation detection unit 10 is a flowchart showing the control process performed by the recirculation detection unit of the blood purification device according to the second embodiment of the present invention during the measurement process.
  • Graph illustrating the measurement process by the recirculation detection unit 10 is a flowchart showing the control content during the measurement process by the recirculation detection unit of the blood purification device according to the third embodiment of the present invention.
  • Graph illustrating the measurement process by the recirculation detection unit 10 is a flowchart showing the control content during the measurement process by the recirculation detection unit of the blood purification device according to the fourth embodiment of the present invention.
  • Graph illustrating the measurement process by the recirculation detection unit 10 is a flowchart showing the control content during the measurement process by the recirculation detection unit of the blood purification device according to the fifth embodiment of the present invention.
  • the blood circuit 1 is primarily composed of an arterial blood circuit 1a and a venous blood circuit 1b, each made of flexible tubes, with a dialyzer 2 connected between the arterial blood circuit 1a and the venous blood circuit 1b.
  • An arterial puncture needle a is connected to the tip of the arterial blood circuit 1a, and a peristaltic blood pump 3, a debubbling air trap chamber 4a, and a first detection unit 5a are disposed along the way.
  • a venous puncture needle b is connected to the tip of the venous blood circuit 1b, and a second detection unit 5b and a debubbling air trap chamber 4b are connected along the way.
  • the blood pump 3 when the blood pump 3 is driven with the arterial puncture needle a and the venous puncture needle b inserted into the patient, the patient's blood passes through the arterial blood circuit 1a and reaches the dialyzer 2 while being debubbled in the air trap chamber 4a. After being purified by the dialyzer 2, the patient's blood passes through the venous blood circuit 1b while being debubbled in the air trap chamber 4b and returns to the patient's body. In this way, the patient's blood can be circulated extracorporeally through the blood circuit 1 while being purified by the dialyzer 2.
  • the dialyzer 2 has a blood inlet port 2a, a blood outlet port 2b, a dialysate inlet port 2c, and a dialysate outlet port 2d formed in its housing.
  • the blood inlet port 2a is connected to the base end of the arterial blood circuit 1a
  • the blood outlet port 2b is connected to the base end of the venous blood circuit 1b.
  • the dialysate inlet port 2c and dialysate outlet port 2d are connected to a dialysate inlet line 7 and a dialysate outlet line 8, respectively, which extend from the dialysis device main body 6.
  • the dialyzer 2 contains multiple hollow fibers, the interior of which serves as a blood flow path, and the space between the outer circumferential surface of the hollow fibers and the inner circumferential surface of the housing serves as a dialysate flow path.
  • the hollow fibers have numerous tiny pores that penetrate from their outer circumferential surface to their inner circumferential surface, forming hollow fiber membranes that allow impurities in the blood to pass through into the dialysate.
  • the duplex pump C is disposed across the dialysate inlet line 7 and the dialysate outlet line 8, and serves to introduce dialysate from the dialysate inlet line 7 to the dialyzer 2 and to discharge the dialysate introduced into the dialyzer 2 from the dialysate outlet line 8.
  • a supply line La is connected to the dialysate introduction line 7 in this embodiment.
  • This supply line La is capable of supplying dialysate as a replacement fluid to the blood circuit 1, and its base end is connected to a portion of the dialysate introduction line 7 between the supply side Ca of the duplex pump C and the dialysate introduction port 2c of the dialyzer 2, while its tip branches into a pre-replacement fluid supply line La1 and a post-replacement fluid supply line La2, which are connected to the air trap chamber 4a of the arterial blood circuit 1a and the air trap chamber 4b of the venous blood circuit 1b, respectively.
  • a fluid replacement pump 15 which is a peristaltic pump similar to the blood pump 3, is provided on this supply line La.
  • the dialysate in the dialysate introduction line 7 is supplied to the arterial blood circuit 1a via the pre-fluid replacement supply line La1, enabling pre-fluid replacement, and to the venous blood circuit 1b via the post-fluid replacement supply line La2, enabling post-fluid replacement.
  • the atmosphere vent line 13 and solenoid valve 14 constitute the characteristic change imparting unit of the present invention, and by operating the solenoid valve 14 to open the atmosphere vent line 13, a local concentration change (characteristic change) with a unique peak can be imparted to the blood flowing through the dialyzer 2 by rapid and short-term concentration.
  • a local concentration change characteristic change
  • the outlet pressure of the pressure pump 11 becomes approximately equal to atmospheric pressure, and a momentary high negative pressure is generated upstream of the pressure pump 11, causing rapid and short-term water removal (hemoconcentration) of the blood flowing through the dialyzer 2 (blood flow path).
  • the solenoid valve 14 opens the atmosphere vent line 13 for a short time (in this embodiment, the opening of the atmosphere vent line 13 can be set to any time less than 10 seconds, and even 1 second provides sufficient measurement accuracy), and the solenoid valve 14 is immediately operated to close the atmosphere vent line 13.
  • the time that the solenoid valve 14 opens the atmospheric vent line 13 is preferably automatically controlled to be optimal based on blood concentration information (information about the patient's blood concentration) and pressure information (venous pressure, dialysis fluid pressure, etc.).
  • blood concentration information information about the patient's blood concentration
  • pressure information venous pressure, dialysis fluid pressure, etc.
  • “sudden and short-term” refers to a magnitude and duration that allows the applied pulse to be confirmed after passing through the circuit
  • "unique” refers to a fluctuation pattern that can be distinguished from fluctuations caused by other factors such as pump fluctuations or patient movement.
  • the first and second detectors 5a and 5b are disposed in the arterial and venous blood circuits 1a and 1b, respectively, and detect the concentration (specifically, the hematocrit value) of the blood flowing through these channels.
  • the first and second detectors 5a and 5b are composed of hematocrit sensors equipped with a light-emitting element such as an LED and a light-receiving element such as a photodiode, and are configured to detect the hematocrit value, which indicates the concentration of the patient's blood, by irradiating light onto the blood from the light-emitting element and receiving the transmitted or reflected light with the light-receiving element.
  • the first detection unit 5a and the second detection unit 5b determine the hematocrit value, which indicates the blood concentration, based on the electrical signal output from the light-receiving element.
  • Each component of blood such as red blood cells and plasma, has its own unique light absorption characteristics, and this property can be used to electro-optically quantify the red blood cells required to measure the hematocrit value, thereby determining the hematocrit value.
  • near-infrared light emitted from the light-emitting element is affected by absorption and scattering when it enters the blood and is received by the light-receiving element.
  • the hematocrit value can then be calculated by analyzing the light absorption and scattering rate from the intensity of the received light.
  • the control unit 16 is composed of, for example, a microcomputer, and as shown in FIG. 2, is electrically connected to pumps such as a duplex pump C that introduces and extracts dialysate to the dialyzer 2 (blood purification unit), a blood pump 3 arranged in the blood circuit 1, a water removal pump 10 that removes water from the blood circulating extracorporeally through the blood circuit 1, a pressure pump 11, a replacement fluid pump 15 that introduces replacement fluid (dialysis fluid) into the blood circuit, and a drug injection pump (not shown) that injects drug solutions such as heparin into the blood circuit 1, as well as solenoid valves such as solenoid valve 14 that can impart localized concentration changes that form peaks specific to changes in blood concentration, and is capable of controlling these pumps and solenoid valves.
  • pumps such as a duplex pump C that introduces and extracts dialysate to the dialyzer 2 (blood purification unit), a blood pump 3 arranged in the blood circuit 1, a water removal pump 10 that removes water from the blood
  • the first detection unit 5a and second detection unit 5b in this embodiment are electrically connected to a recirculation detection unit 17 arranged in the dialysis device main body 6, and the recirculation detection unit 17 is electrically connected to a display unit 18 consisting of a touch panel.
  • the display unit 18 displays a graph of the local concentration changes ⁇ and ⁇ detected by the first detection unit 5a and second detection unit 5b, and in addition to this graph display, it is also capable of displaying the ratio of recirculated blood calculated by the recirculation detection unit 17 as a numerical value, etc.
  • the monitoring unit 17a monitors changes in blood concentration detected by the first detection unit 5a and the second detection unit 5b over time during blood purification treatment.
  • the graph creation unit 17b creates a graph showing local concentration changes ⁇ and ⁇ based on the changes in blood concentration monitored over time by the monitoring unit 17a, and the calculation unit 17c calculates the proportion of recirculated blood (recirculation rate) based on the graph created by the graph creation unit 17b.
  • the changes in blood concentration monitored by the monitoring unit 17a, the graph created by the graph creation unit 17b, and the proportion of recirculated blood (recirculation rate) calculated by the calculation unit 17c are stored in the memory unit 17d.
  • the recirculation detection unit 17 determines the change in hematocrit value (concentration change) of the first detection unit 5a and the second detection unit 5b based on a graph such as that shown in Figure 4, with the horizontal axis representing elapsed time (cumulative flow rate or time) and the vertical axis representing blood concentration (hematocrit value), and calculates the area S1 of the local concentration change ⁇ where characteristic peak P1 is formed and the area S2 of the local concentration change ⁇ where characteristic peak P2 is formed using a mathematical method such as integration.
  • the proportion of recirculated blood (recirculation rate) Rrec can then be calculated using the following formula:
  • the proportion of recirculated blood (recirculation rate) Rrec calculated in this manner is displayed on the display unit 18 so that it can be visually confirmed by doctors and other medical professionals. If there is no blood recirculation, the above S2 will be 0, and the value displayed as the proportion of recirculated blood will be 0 (%). Furthermore, in addition to the recirculation rate, the display unit 18 in this embodiment is capable of graphically displaying the local concentration changes detected by the first detection unit 5a and the second detection unit 5b, as shown in Figure 4, and is able to display the local concentration change ⁇ where the characteristic peak P1 is formed and the local concentration change ⁇ where the characteristic peak P2 is formed, each as a curve graph.
  • the recirculation detection unit 17 creates a graph showing local concentration changes ⁇ and ⁇ , with the horizontal axis representing elapsed time (cumulative flow rate or time) and the vertical axis representing blood concentration (hematocrit value), as shown in Figure 4, based on the blood concentration detected by the first detection unit 5a and the second detection unit 5b, and monitors the changes in blood concentration at a predetermined interval (e.g., 0.1 second interval).
  • a predetermined interval e.g., 0.1 second interval
  • the recirculation detection unit 17 is configured to detect a noise waveform ⁇ detected immediately before a local concentration change ⁇ is detected, and to identify the start time point R1 of the local concentration change ⁇ based on the noise waveform ⁇ .
  • This noise waveform ⁇ is generated as a precursor noise of the local concentration change ⁇ detected by the second detection unit 5b when the solenoid valve 14 constituting the characteristic change imparting unit is changed from a closed state to an open state to impart a local concentration change.
  • the recirculation detection unit 17 identifies the point in time when the concentration change changes from a decrease to an increase as the start point R1 of the local concentration change ⁇ . For example, the maximum or minimum value of the detected blood concentration value is updated sequentially at each predetermined cycle, and the concentration change is considered to have decreased when the blood concentration value decreases from the maximum value, and to have increased when the blood concentration value increases from the minimum value.
  • the peaks of the waveforms in the graph can be found by calculating the maximum value of each waveform.
  • the slope for each predetermined cycle can be found using a calculation method such as the least squares method for the curve within the cycle, and the area for each predetermined cycle can be found using a calculation method such as integration for the curve within the cycle.
  • the process of detecting recirculated blood using the recirculation detection unit 17 and calculating the proportion of recirculated blood is performed in a measurement process separate from the treatment process in which blood purification treatment is performed.
  • the control unit 16 changes the parameters for driving the pumps to be controlled (duplex pump C, blood pump 3, water removal pump 10, pressure pump 11, fluid replacement pump 15, drug injection pump, etc.) to measurement parameters that are different from those used during the treatment process in which blood purification treatment is performed.
  • This measurement process will be explained based on the flowchart in Figure 5.
  • the measurement process begins upon input operation of the switch input unit SW1 by the operator.
  • the control unit 16 temporarily changes the pump to be controlled to the measurement parameters and drives the pump based on those measurement parameters.
  • the system waits until the blood concentration detected by the first detection unit 5a and the second detection unit 5b stabilizes.
  • These measurement parameters consist of parameters that slow the drive speed of the pump (the pump to be controlled) down from that during the treatment process or stop the pump.
  • the system proceeds to S3, where the solenoid valve 14 is operated to open the atmosphere vent line 13, thereby creating localized concentration changes with characteristic peaks P1 and P2.
  • the process proceeds to S4, where the recirculation detection unit 17 detects recirculated blood and calculates the proportion of recirculated blood (recirculation rate) based on the local concentration change ⁇ detected by the first detection unit 5a and the local concentration change ⁇ detected by the second detection unit 5b.
  • the calculated proportion of recirculated blood (recirculation rate) is displayed on the display unit 18 to prompt a medical professional such as a doctor to take action.
  • the process proceeds to S5, where the control unit 16 reverts from measurement parameters to treatment parameters, provided that the operator operates the switch input unit SW1. This completes the measurement process, and blood purification treatment can be performed based on the treatment parameters.
  • the recirculation detection unit 17 detects the noise waveform ⁇ in Sa1, and when the noise waveform ⁇ is detected, the end of the noise waveform ⁇ is detected in Sa2.
  • the end of the noise waveform ⁇ can be found by detecting the peak P3 of the noise waveform ⁇ and detecting the point in time from peak P3 when the concentration change changes from a decrease to an increase, and this end can be taken as the start point R1 of the local concentration change ⁇ .
  • the blood purification device purifies a patient's blood while circulating it extracorporeally, and is applied to a hemodialysis device used in hemodialysis treatment.
  • this hemodialysis device comprises a blood circuit 1 connected to a dialyzer 2 as a blood purification unit, a dialysis device main body 6 that supplies dialysate to the dialyzer 2 while removing water from the dialyzer 2, and a control unit 16, a recirculation detection unit 17, and a display unit 18 disposed in the dialysis device main body 6.
  • the same components as those in the first embodiment are designated by the same reference numerals, and detailed descriptions thereof will be omitted.
  • the recirculation detection unit 17 in this embodiment is configured, for example, with a microcomputer, and is capable of detecting recirculated blood, which is blood returned to the patient from the venous blood circuit 1b and then guided back into the arterial blood circuit 1a, based on the local concentration change ⁇ detected by the first detection unit 5a and the local concentration change ⁇ detected by the second detection unit 5b, and calculating the proportion of recirculated blood (recirculation rate).
  • the waveform peaks in the graph can be found by calculating the maximum value of each waveform, as in the first embodiment.
  • the slope for each predetermined cycle can be found using a calculation method such as the least squares method for the curve within the cycle, as in the first embodiment, and the area for each predetermined cycle can be found using a calculation method such as integration for the curve within the cycle.
  • the process of detecting recirculated blood using the recirculation detection unit 17 and calculating the proportion of recirculated blood is performed in a measurement process separate from the treatment process in which blood purification treatment is performed.
  • the control unit 16 controls the pumps to be controlled (duplex pump C, blood pump 3, water removal pump 10, pressure pump 11, fluid replacement pump 15, drug injection pump, etc.) by changing the parameters for driving them to measurement parameters that are different from those used during the treatment process in which blood purification treatment is performed.
  • This measurement process is as described in the first embodiment based on the flowchart in Figure 5.
  • the areas S1 and S2 shown in Figure 4 are calculated based on the start time R1 and end time R2 of the local concentration change ⁇ at which the characteristic peak P1 is formed, and the start time W1 and end time W2 of the local concentration change ⁇ at which the characteristic peak P2 is formed, and the recirculation rate (Rrec (%)), which is the proportion of recirculated blood, can be calculated from the ratio of these areas S1 and S2.
  • the recirculation detection unit 17 creates a graph showing local concentration changes ⁇ and ⁇ , with the horizontal axis representing elapsed time (cumulative flow rate or time) and the vertical axis representing blood concentration (hematocrit value), as shown in Figure 4, based on the blood concentration detected by the first detection unit 5a and the second detection unit 5b, and monitors the blood concentration changes at a predetermined interval (e.g., 0.1 second interval).
  • a predetermined interval e.g., 0.1 second interval
  • the recirculation detection unit 17 is configured to detect the amount of change in the local concentration change ⁇ over time or with the cumulative blood flow rate after the characteristic peak P1 is detected, and identify the point at which the amount of change changes from a decrease to an increase as the end point R2 of the local concentration change ⁇ . Specifically, the recirculation detection unit 17 sequentially (every cycle in this embodiment) calculates the value of the blood concentration on the graph after the characteristic peak P1 in the local concentration change ⁇ is detected, and identifies the point at which the calculated value of the blood concentration on the graph reaches a minimum as the end point R2.
  • the recirculation detection unit 17 can sequentially calculate the blood concentration value on the graph for each period after the characteristic peak P1 in the local concentration change ⁇ is detected, and identify the position where the calculated blood concentration value on the graph changes from a decrease to an increase as the minimum value. Furthermore, if the blood concentration value does not change from a decrease to an increase and remains constant (if the graph is flat), the position where the blood concentration value first changes to a constant value can be identified as the minimum value. Furthermore, if the blood concentration value continues to decrease, the measurement end position can be identified as the minimum value. The peaks of the waveforms in the graph (the characteristic peak P1 of the local concentration change ⁇ and the characteristic peak P2 of the local concentration change ⁇ ) can be found by calculating the maximum value of each waveform.
  • the process proceeds to S4, where the recirculation detection unit 17 detects recirculated blood and calculates the proportion of recirculated blood (recirculation rate) based on the local concentration change ⁇ detected by the first detection unit 5a and the local concentration change ⁇ detected by the second detection unit 5b.
  • the process proceeds to S5, where the control unit 16 reverts from measurement parameters to treatment parameters, provided that the operator operates the switch input unit SW1. This completes the measurement process, and blood purification treatment can be performed based on the treatment parameters.
  • the recirculation detection unit 17 detects the characteristic peak P1 of the local concentration change ⁇ in Sc1.
  • the minimum value of the concentration after the detection of the characteristic peak P1 is detected in Sc2. This minimum value can be obtained by sequentially calculating the value of the blood concentration on the graph after the characteristic peak P1 of the local concentration change ⁇ is detected, and the point at which the calculated value of the blood concentration on the graph reaches the minimum can be identified as the end point R2.
  • the recirculation detection unit 17 sequentially calculates the blood concentration value on the graph after the characteristic peak P1 in the local concentration change ⁇ is detected, and identifies the point at which the calculated blood concentration value on the graph reaches its minimum as the end point R2.Therefore, by determining the minimum value of the blood concentration after the characteristic peak P1 and accurately detecting at least the end point R2 of the local concentration change ⁇ , the proportion of recirculated blood can be calculated with high precision.
  • the blood purification device purifies a patient's blood while circulating it extracorporeally, and is applied to a hemodialysis device used in hemodialysis treatment.
  • this hemodialysis device comprises a blood circuit 1 connected to a dialyzer 2 as a blood purification unit, a dialysis device main body 6 that supplies dialysate to the dialyzer 2 while removing water from the dialyzer 2, and a control unit 16, a recirculation detection unit 17, and a display unit 18 disposed in the dialysis device main body 6.
  • the same components as those in the first embodiment are designated by the same reference numerals, and detailed descriptions thereof will be omitted.
  • the recirculation detection unit 17 creates a graph showing local concentration changes ⁇ and ⁇ , with the horizontal axis representing elapsed time (cumulative flow rate or time) and the vertical axis representing blood concentration (hematocrit value), as shown in Figure 4, based on the blood concentration detected by the first detection unit 5a and the second detection unit 5b, and monitors the blood concentration changes at a predetermined interval (e.g., 0.1 second interval).
  • a predetermined interval e.g., 0.1 second interval
  • the recirculation detection unit 17 in this embodiment is configured, for example, with a microcomputer, and is capable of detecting recirculated blood, which is blood returned to the patient from the venous blood circuit 1b and then guided back into the arterial blood circuit 1a, based on the local concentration change ⁇ detected by the first detection unit 5a and the local concentration change ⁇ detected by the second detection unit 5b, and calculating the proportion of recirculated blood (recirculation rate).
  • the process of detecting recirculated blood using the recirculation detection unit 17 and calculating the proportion of recirculated blood is performed in a measurement process separate from the treatment process in which blood purification treatment is performed.
  • the control unit 16 controls the pumps to be controlled (duplex pump C, blood pump 3, water removal pump 10, pressure pump 11, fluid replacement pump 15, drug injection pump, etc.) by changing the parameters for driving them to measurement parameters that are different from those used during the treatment process in which blood purification treatment is performed.
  • This measurement process is as described in the first embodiment based on the flowchart in Figure 5.
  • the recirculation detection unit 17 creates a graph showing local concentration changes ⁇ and ⁇ , with the horizontal axis representing elapsed time (cumulative flow rate or time) and the vertical axis representing blood concentration (hematocrit value), as shown in Figure 5, based on the blood concentration detected by the first detection unit 5a and the second detection unit 5b, and monitors the changes in blood concentration at a predetermined interval (e.g., 0.1 second interval).
  • a predetermined interval e.g., 0.1 second interval
  • the recirculation detection unit 17 in this embodiment is configured, for example, with a microcomputer, and is capable of detecting recirculated blood, which is blood returned to the patient from the venous blood circuit 1b and then guided back into the arterial blood circuit 1a, based on the local concentration change ⁇ detected by the first detection unit 5a and the local concentration change ⁇ detected by the second detection unit 5b, and calculating the proportion of recirculated blood (recirculation rate).
  • the recirculation detection unit 17 is configured to sequentially (for each cycle in this embodiment) calculate the area of the graph (the area Sn of the region between two points in the figure) after the characteristic peak P1 of the local concentration change ⁇ is detected, as shown in FIG. 15, and identify the point at which the rate of change of the calculated area of the graph decreases as the end point R2.
  • the waveform peaks in the graph can be found by calculating the maximum value of each waveform, as in the first embodiment.
  • the area for each predetermined cycle can be found using an arithmetic method such as integration on the curve within the cycle.
  • the process of detecting recirculated blood using the recirculation detection unit 17 and calculating the proportion of recirculated blood is performed in a measurement process separate from the treatment process in which blood purification treatment is performed.
  • the control unit 16 controls the pumps to be controlled (duplex pump C, blood pump 3, water removal pump 10, pressure pump 11, fluid replacement pump 15, etc.) by changing the parameters for driving them to measurement parameters that are different from those used during the treatment process in which blood purification treatment is performed.
  • This measurement process is as described in the first embodiment based on the flowchart in Figure 5.
  • Se1 detects a specific peak P1 of the local concentration change ⁇ by the recirculation detection unit 17. Then, after the specific peak P1 is detected, the process proceeds to Se2, where the area of the graph after the specific peak P1 is detected is calculated sequentially, and the point in time at which the rate of change of the calculated area of the graph decreases is identified as the end point R2.
  • the recirculation detection unit 17 sequentially calculates the area of the graph after the characteristic peak P1 in the local concentration change ⁇ is detected, and identifies the point at which the rate of change in the calculated graph area decreases as the end point R2.Therefore, by determining the area of the graph after the characteristic peak P1 and accurately detecting at least the end point R2 of the local concentration change ⁇ , the proportion of recirculated blood can be calculated with high accuracy.
  • the characteristic change imparting unit is not limited to being composed of the air vent line 13 and solenoid valve 14, and other means may be used as long as it is capable of imparting a local concentration change with a unique peak.
  • the characteristic change imparting unit in this embodiment locally changes the blood concentration by concentrating the blood through water removal, it is also possible to locally change the blood concentration by diluting the blood, for example, by introducing a replacement fluid (dialysis fluid) such as replacement fluid into the blood circuit.
  • a replacement fluid dialysis fluid
  • first detector 5a and the second detector 5b may be configured with something other than a hematocrit sensor (for example, a sensor that detects hemoglobin concentration or a sensor that detects the concentration of proteins, etc.) as long as it can detect changes in blood concentration that form a unique peak.
  • first detector 5a and the second detector 5b may be disposed at any location on the arterial blood circuit 1a and the venous blood circuit 1b, respectively.
  • the change in blood characteristics in this embodiment is a change in blood concentration
  • it may also be a change in other characteristics, such as a change in blood temperature.
  • ultrasound may be used to inject a marker (saline or microbubbles) into the blood flow, measure the dilution curve using an ultrasound probe, and capture changes in blood flow within the blood circuit in real time, making it possible to quantify the recirculation rate.
  • it may be a method for evaluating recirculation by injecting a dye into the arterial blood circuit and measuring absorbance in the venous blood circuit, or a method for injecting cooled saline into the blood circuit and measuring changes in blood temperature, with temperature sensors placed in the arterial and venous blood circuits to calculate the recirculation rate from the rate of temperature change.
  • NIRS near-infrared spectroscopy
  • the first embodiment of the present invention is a blood purification device that circulates a patient's blood extracorporeally through a blood circuit 1 having an arterial blood circuit 1a and a venous blood circuit 1b, and purifies the blood.
  • the device comprises a characteristic change imparting unit (air vent line 13 and solenoid valve 14) that can impart local concentration changes that form peaks specific to the concentration changes of the blood circulating extracorporeally through the blood circuit 1, and a first detection unit 5a and a second detection unit 5b that are attached to the arterial blood circuit 1a and the venous blood circuit 1b, respectively, and that detect the local concentration changes ⁇ and ⁇ imparted by the characteristic change imparting unit.
  • the system includes a second detection unit (5b), and a recirculation detection unit (17) that detects recirculated blood, which is blood returned to the patient from the venous blood circuit (1b) and re-circulated into the arterial blood circuit (1a) based on the local concentration change ( ⁇ ) detected by the first detection unit (5a) and the local concentration change ( ⁇ ) detected by the second detection unit (5b), and calculates the proportion of recirculated blood.
  • the recirculation detection unit (17) detects a noise waveform ( ⁇ ) detected just before the local concentration change is detected, and identifies the start time (R1) of the local concentration change ( ⁇ ) based on the noise waveform ( ⁇ ). This allows the proportion of recirculated blood to be calculated with high accuracy by accurately detecting at least the start time (R1) of the local concentration change ( ⁇ ) using the noise waveform ( ⁇ ).
  • a third embodiment of the present invention is a second embodiment in which the recirculation detection unit 17 sequentially detects the slope or area for each predetermined period in a graph showing concentration changes over time or with the cumulative blood flow rate, and detects decreases and increases in concentration changes based on the detected changes in slope or area. This makes it possible to smoothly and accurately identify the start point R1 of a local concentration change ⁇ using the noise waveform ⁇ .
  • a fourth embodiment of the present invention is a blood purification device that circulates a patient's blood extracorporeally through a blood circuit 1 having an arterial blood circuit 1a and a venous blood circuit 1b, and purifies the blood.
  • the device comprises a characteristic change imparting unit (air vent line 13 and solenoid valve 14) that can impart local concentration changes that form peaks specific to the concentration changes in the blood circulating extracorporeally through the blood circuit 1, a first detection unit 5a and a second detection unit 5b that are attached to the arterial blood circuit 1a and the venous blood circuit 1b, respectively, and that detect the local concentration changes ⁇ and ⁇ imparted by the characteristic change imparting unit, and
  • the system is equipped with a recirculation detection unit 17 that detects recirculated blood, which is blood returned to the patient from the venous blood circuit 1b and then introduced back into the arterial blood circuit 1a, based on the detected local concentration change ⁇ and the local concentration change ⁇ detected by the second detection unit 5b, and calculates
  • the recirculation detection unit 17 sequentially detects the slope or area for each predetermined period in a graph showing concentration changes over time or with the cumulative blood flow rate, and detects decreases and increases in concentration changes based on the detected changes in slope or area. This makes it possible to smoothly and accurately identify the start point R1 of a local concentration change ⁇ by utilizing a specific peak P1.
  • a sixth embodiment of the present invention is a blood purification device that circulates a patient's blood extracorporeally through a blood circuit 1 having an arterial blood circuit 1a and a venous blood circuit 1b, and purifies the blood.
  • the device comprises a characteristic change imparting unit (air vent line 13 and solenoid valve 14) that can impart local concentration changes that form peaks specific to the concentration changes in the blood circulating extracorporeally through the blood circuit 1, a first detection unit 5a and a second detection unit 5b that are attached to the arterial blood circuit 1a and the venous blood circuit 1b, respectively, and that detect the local concentration changes ⁇ and ⁇ imparted by the characteristic change imparting unit, and a second detection unit 5b that detects the local concentration changes ⁇ and ⁇ imparted by the characteristic change imparting unit.
  • a characteristic change imparting unit air vent line 13 and solenoid valve 14
  • This blood purification device is equipped with a recirculation detection unit 17 that detects recirculated blood, where blood returned to the patient from the venous blood circuit 1b is guided back into the arterial blood circuit 1a and flows, based on the local concentration change ⁇ detected by the first detection unit 5b and the local concentration change ⁇ detected by the second detection unit 5b, and calculates the proportion of recirculated blood.
  • the recirculation detection unit 17 detects the amount of change in the local concentration change ⁇ over time or with the integrated blood flow rate after the detection of the characteristic peak P1, and identifies the point at which the amount of change changes from a decrease to an increase as the end point R2 of the local concentration change ⁇ .This allows the proportion of recirculated blood to be calculated with high accuracy by accurately detecting at least the end point R2 of the local concentration change ⁇ .
  • the recirculation detection unit 17 sequentially calculates the blood concentration value on the graph after a characteristic peak P1 in the local concentration change ⁇ is detected, and identifies the point in time at which the calculated blood concentration value on the graph reaches its minimum as the end point R2. This makes it possible to determine the minimum value after the characteristic peak P1 is detected, and accurately identify the end point R2 of the local concentration change ⁇ .
  • the recirculation detection unit 17 sequentially calculates the slope of the graph after a characteristic peak P1 in the local concentration change ⁇ is detected, and identifies the point in time at which the calculated slope of the graph becomes horizontal as the end point R2. This makes it possible to determine the slope of the graph after the characteristic peak P1 is detected, and accurately identify the end point R2 of the local concentration change ⁇ .
  • a ninth embodiment of the present invention is a sixth embodiment in which the recirculation detection unit 17 sequentially calculates the area of the graph after a characteristic peak P1 in the local concentration change ⁇ is detected, and identifies the point in time at which the rate of change in the calculated graph area decreases as the end point R2. This makes it possible to determine the area of the graph after the characteristic peak P1 is detected, and accurately identify the end point R2 of the local concentration change ⁇ .
  • An eleventh embodiment of the present invention is the tenth embodiment, further comprising a switching input unit or instruction input unit that can be operated by an operator, and the measurement process is performed as a predetermined step, conditional on input operation of the switching input unit or instruction input unit.
  • a twelfth embodiment of the present invention is any one of the first, fourth, and sixth embodiments, in which the blood characteristic is blood concentration. This makes it possible to detect recirculating blood based on changes in blood concentration and calculate the proportion of recirculating blood.
  • Blood circuit 1a Arterial blood circuit 1b Venous blood circuit 2 Dialyzer (blood purification section) 3 Blood pump 4a, 4b Air trap chamber 5a First detection unit 5b Second detection unit 6 Dialysis device main body 7 Dialysis fluid introduction line 8 Dialysis fluid discharge line 9 Bypass line 10 Water removal pump 11 Pressurizing pump 12 Air bubble separation chamber 13 Atmospheric release line 14 Solenoid valve 15 Infusion fluid pump 16 Control unit 17 Recirculation detection unit 18 Display unit C Duplex pump La Supply line La1 Pre-infusion fluid supply line La2 Post-infusion fluid supply line SW1 Switching input unit SW2 Instruction input unit

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • External Artificial Organs (AREA)

Abstract

Provided is a blood purification device capable of calculating a proportion of recirculated blood with high accuracy by accurately detecting a start point of time of at least a local characteristic change. The present invention is provided with: a characteristic change imparting unit that can impart a local concentration change in which a peak specific to concentration changes in blood circulating extracorporeally in a blood circuit 1 is formed; a first detection unit 5a and a second detection unit 5b that detect the local concentration change imparted by the characteristic change imparting unit; and a recirculation detection unit 17 that detects recirculating blood on the basis of a local concentration change β detected by the first detection unit 5a and a local concentration change α detected by the second detection unit 5b, and that calculates the proportion of recirculating blood. The recirculation detection unit 17 detects a noise waveform γ detected immediately before detection of the local concentration changes and identifies a start time point R1 of the local concentration change α on the basis of the noise waveform γ.

Description

血液浄化装置Blood purification device

 本発明は、静脈側血液回路から患者に戻された血液が再び動脈側血液回路に導かれて流れる再循環血液を検出する血液浄化装置に関するものである。 The present invention relates to a blood purification device that detects recirculated blood, which is blood returned to a patient from a venous blood circuit and then guided back into an arterial blood circuit.

 一般に、血液浄化療法、例えば血液透析治療においては、血液回路で患者の血液を体外循環させるとともに、ダイアライザにより血液浄化が行われる。しかしながら、例えば動脈側穿刺針及び静脈側穿刺針を患者のシャント(外科手術により動脈と静脈とを連結させた部位)に穿刺し体外循環を行わせる際、静脈側穿刺針から浄化されて患者の体内に戻された血液が、患者の臓器等を経ず再び動脈側穿刺針から血液回路に導入して流れる再循環血液が生じることがある。このような再循環血液が生じると、浄化した血液を更に体外循環させることとなり、その分だけ浄化が必要な血液の体外循環量が減少するので、血液浄化効率が低下してしまうという課題が生じてしまう。 Generally, in blood purification therapies, such as hemodialysis, a patient's blood is circulated extracorporeally through a blood circuit, and purified using a dialyzer. However, when, for example, an arterial puncture needle and a venous puncture needle are inserted into a patient's shunt (a site where an artery and a vein are connected by surgery) to perform extracorporeal circulation, blood that has been purified and returned to the patient's body through the venous puncture needle can sometimes become recirculated blood, where the purified blood is introduced back into the blood circuit through the arterial puncture needle without passing through the patient's organs. When this recirculation occurs, the purified blood must be further circulated extracorporeally, which reduces the amount of blood that needs to be purified that is circulating extracorporeally, resulting in a problem of reduced blood purification efficiency.

 かかる再循環血液を検出するため、例えば特許文献1にて開示されているように、除水ポンプを駆動させることにより体外循環する血液の濃度の変化に特有のピークを付与し、これを目印として血液再循環を検出し得る透析装置が提案されている。かかる文献で開示された透析装置によれば、血液濃度を検出するセンサ(ヘモグロビン濃度を検出するセンサ)が動脈側血液回路に配設されており、かかるセンサにて特有のピークを検出することで透析治療中における血液再循環を検知することができる。 In order to detect such recirculated blood, as disclosed in Patent Document 1, for example, a dialysis machine has been proposed that operates a water removal pump to give a specific peak to the change in concentration of blood circulating extracorporeally, and uses this as a marker to detect blood recirculation. According to the dialysis machine disclosed in this document, a sensor that detects blood concentration (a sensor that detects hemoglobin concentration) is placed in the arterial blood circuit, and blood recirculation during dialysis treatment can be detected by detecting the specific peak with this sensor.

特表2000-502940号公報Special Publication No. 2000-502940

 しかしながら、従来の血液浄化装置においては、再循環率や患者のシャントの流量を求めるために再循環血液の比率を算出する場合、以下の課題がある。
 局所的な濃度変化を付与した場合、患者の状態や治療環境等によって検出される局所的な濃度変化が種々異なることがあり、再循環血液の比率を高精度に算出するためには、局所的な濃度変化の開始時点及び終了時点を正確に把握する必要がある。そこで、本出願人は、再循環血液の比率を高精度に算出するため、少なくとも局所的な濃度変化の開始時点を精度よく検出するため鋭意検討するに至った。なお、血液の濃度に代えて、血液の温度等、血液の他の特性の変化に基づいて再循環血液の比率を算出するものも同様な課題がある。ここで、血液の特性とは、血液の濃度に限らず、血液の温度など血液の特性全般を含むものである。
However, in conventional blood purification devices, when calculating the proportion of recirculated blood to determine the recirculation rate or the flow rate of the patient's shunt, the following problems arise.
When a local concentration change is applied, the detected local concentration change may vary depending on the patient's condition, the treatment environment, etc., and in order to accurately calculate the proportion of recirculated blood, it is necessary to accurately grasp the start and end points of the local concentration change. Therefore, the present applicant has conducted extensive research to accurately detect at least the start point of the local concentration change in order to accurately calculate the proportion of recirculated blood. Similar issues also exist when calculating the proportion of recirculated blood based on changes in other blood characteristics, such as blood temperature, instead of blood concentration. Here, the blood characteristics are not limited to blood concentration but include general blood characteristics, such as blood temperature.

 本発明は、このような事情に鑑みてなされたもので、少なくとも局所的な特性変化の開始時点又は終了時点を精度よく検出することにより再循環血液の比率を高精度に算出することができる血液浄化装置を提供することにある。 The present invention was made in consideration of these circumstances, and aims to provide a blood purification device that can accurately calculate the proportion of recirculated blood by accurately detecting at least the start or end point of a local characteristic change.

 本発明に係る一の実施形態は、動脈側血液回路及び静脈側血液回路を有した血液回路を通して患者の血液を体外循環させ、血液を浄化する血液浄化装置であって、前記血液回路を体外循環する血液の特性変化に特有のピークが形成された局所的な特性変化を付与し得る特性変化付与部と、前記動脈側血液回路及び静脈側血液回路にそれぞれ取り付けられ、前記特性変化付与部で付与された局所的な特性変化を検出する第1検出部及び第2検出部と、前記第1検出部で検出された局所的な特性変化と前記第2検出部で検出された局所的な特性変化とに基づいて、前記静脈側血液回路から患者に戻された血液が再び前記動脈側血液回路に導かれて流れる再循環血液を検出し、前記再循環血液の比率を算出する再循環検出部とを具備し、前記再循環検出部は、前記局所的な特性変化が検出される直前に検出されるノイズ波形を検出するとともに、前記ノイズ波形に基づいて前記局所的な特性変化の開始時点を特定する血液浄化装置である。 One embodiment of the present invention is a blood purification device that circulates a patient's blood extracorporeally through a blood circuit having an arterial blood circuit and a venous blood circuit, and purifies the blood. The blood purification device includes: a characteristic change imparting unit that can impart a local characteristic change with a peak that is specific to the characteristic change of the blood circulating extracorporeally through the blood circuit; a first detection unit and a second detection unit that are attached to the arterial blood circuit and the venous blood circuit, respectively, and detect the local characteristic change imparted by the characteristic change imparting unit; and a recirculation detection unit that detects recirculated blood, which is blood returned to the patient from the venous blood circuit and then guided back into the arterial blood circuit based on the local characteristic change detected by the first detection unit and the local characteristic change detected by the second detection unit, and calculates the proportion of recirculated blood. The recirculation detection unit detects a noise waveform detected immediately before the local characteristic change is detected, and identifies the start point of the local characteristic change based on the noise waveform.

 また、本発明に係る他の実施形態は、動脈側血液回路及び静脈側血液回路を有した血液回路を通して患者の血液を体外循環させ、血液を浄化する血液浄化装置であって、前記血液回路を体外循環する血液の特性変化に特有のピークが形成された局所的な特性変化を付与し得る特性変化付与部と、前記動脈側血液回路及び静脈側血液回路にそれぞれ取り付けられ、前記特性変化付与部で付与された局所的な特性変化を検出する第1検出部及び第2検出部と、前記第1検出部で検出された局所的な特性変化と前記第2検出部で検出された局所的な特性変化とに基づいて、前記静脈側血液回路から患者に戻された血液が再び前記動脈側血液回路に導かれて流れる再循環血液を検出し、前記再循環血液の比率を算出する再循環検出部とを具備し、前記再循環検出部は、前記局所的な特性変化における特定のピークが検出された時点を基準として、前記局所的な特性変化の検出開始時に遡って順次検索し、前記特性変化が減少から増加に変化した時点を前記局所的な特性変化の開始時点として特定する血液浄化装置である。 Another embodiment of the present invention is a blood purification device that circulates a patient's blood extracorporeally through a blood circuit having an arterial blood circuit and a venous blood circuit, and purifies the blood. The blood purification device includes a characteristic change imparting unit that can impart a local characteristic change in which a peak specific to the characteristic change of the blood circulating extracorporeally through the blood circuit is formed; a first detection unit and a second detection unit that are attached to the arterial blood circuit and the venous blood circuit, respectively, and detect the local characteristic change imparted by the characteristic change imparting unit; and a recirculation detection unit that detects recirculated blood, which is blood returned to the patient from the venous blood circuit and then guided back into the arterial blood circuit based on the local characteristic change detected by the first detection unit and the local characteristic change detected by the second detection unit, and calculates the proportion of recirculated blood.The recirculation detection unit sequentially searches back to the start of detection of the local characteristic change, using the time when a specific peak in the local characteristic change was detected as a reference, and identifies the time when the characteristic change changed from a decrease to an increase as the start of the local characteristic change.

 またさらに、本発明に係る他の実施形態は、動脈側血液回路及び静脈側血液回路を有した血液回路を通して患者の血液を体外循環させ、血液を浄化する血液浄化装置であって、前記血液回路を体外循環する血液の特性変化に特有のピークが形成された局所的な特性変化を付与し得る特性変化付与部と、前記動脈側血液回路及び静脈側血液回路にそれぞれ取り付けられ、前記特性変化付与部で付与された局所的な特性変化を検出する第1検出部及び第2検出部と、前記第1検出部で検出された局所的な特性変化と前記第2検出部で検出された局所的な特性変化とに基づいて、前記静脈側血液回路から患者に戻された血液が再び前記動脈側血液回路に導かれて流れる再循環血液を検出し、前記再循環血液の比率を算出する再循環検出部とを具備し、前記再循環検出部は、前記特有のピークが検出された後における前記局所的な特性変化の時間経過または血液の積算流量に伴う変化量を検出し、前記変化量が減少から増加に変化した時点を前記局所的な特性変化の終了時点として特定する血液浄化装置である。 Furthermore, another embodiment of the present invention is a blood purification device that circulates a patient's blood extracorporeally through a blood circuit having an arterial blood circuit and a venous blood circuit, and purifies the blood. The blood purification device includes a characteristic change imparting unit that can impart a local characteristic change in which a peak specific to the characteristic change of the blood circulating extracorporeally through the blood circuit; a first detection unit and a second detection unit that are attached to the arterial blood circuit and the venous blood circuit, respectively, and detect the local characteristic change imparted by the characteristic change imparting unit; and a recirculation detection unit that detects recirculated blood, in which blood returned from the venous blood circuit is guided back into the arterial blood circuit and flows, based on the local characteristic change detected by the first detection unit and the local characteristic change detected by the second detection unit, and calculates the proportion of recirculated blood. The recirculation detection unit detects the amount of change in the local characteristic change over time or with the cumulative blood flow rate after the specific peak is detected, and identifies the point at which the amount of change changes from a decrease to an increase as the end point of the local characteristic change.

 本発明によれば、少なくとも局所的な特性変化の開始時点又は終了時点を精度よく検出することにより再循環血液の比率を高精度に算出することができる。 According to the present invention, the proportion of recirculating blood can be calculated with high accuracy by accurately detecting at least the start or end point of a local characteristic change.

本発明の実施形態に係る血液浄化装置を示す模式図1 is a schematic diagram showing a blood purification device according to an embodiment of the present invention; 同血液浄化装置の主な構成を示すブロック図Block diagram showing the main components of the blood purification device 同血液浄化装置の再循環検出部を示すブロック図FIG. 1 is a block diagram showing the recirculation detection unit of the blood purification device. 同血液浄化装置の第2検出部及び第1検出部で検出された局所的な濃度変化を示すグラフGraph showing local concentration changes detected by the second detection unit and the first detection unit of the blood purification device. 同血液浄化装置の制御部による制御内容を示すフローチャートA flowchart showing the control performed by the control unit of the blood purification device. 本発明の第1の実施形態に係る血液浄化装置の再循環検出部による測定工程時の制御内容を示すフローチャート1 is a flowchart showing the control content during the measurement process by the recirculation detection unit of the blood purification device according to the first embodiment of the present invention. 同再循環検出部による測定工程を説明するためのグラフGraph illustrating the measurement process by the recirculation detection unit 本発明の第2の実施形態に係る血液浄化装置の再循環検出部による測定工程時の制御内容を示すフローチャート10 is a flowchart showing the control process performed by the recirculation detection unit of the blood purification device according to the second embodiment of the present invention during the measurement process. 同再循環検出部による測定工程を説明するためのグラフGraph illustrating the measurement process by the recirculation detection unit 本発明の第3の実施形態に係る血液浄化装置の再循環検出部による測定工程時の制御内容を示すフローチャート10 is a flowchart showing the control content during the measurement process by the recirculation detection unit of the blood purification device according to the third embodiment of the present invention. 同再循環検出部による測定工程を説明するためのグラフGraph illustrating the measurement process by the recirculation detection unit 本発明の第4の実施形態に係る血液浄化装置の再循環検出部による測定工程時の制御内容を示すフローチャート10 is a flowchart showing the control content during the measurement process by the recirculation detection unit of the blood purification device according to the fourth embodiment of the present invention. 同再循環検出部による測定工程を説明するためのグラフGraph illustrating the measurement process by the recirculation detection unit 本発明の第5の実施形態に係る血液浄化装置の再循環検出部による測定工程時の制御内容を示すフローチャート10 is a flowchart showing the control content during the measurement process by the recirculation detection unit of the blood purification device according to the fifth embodiment of the present invention. 同再循環検出部による測定工程を説明するためのグラフGraph illustrating the measurement process by the recirculation detection unit

 以下、本発明の実施形態について図面を参照しながら具体的に説明する。
 本実施形態に係る血液浄化装置は、患者の血液を体外循環させつつ浄化するためのもので、血液透析治療で使用される血液透析装置に適用されたものである。かかる血液透析装置は、図1に示すように、血液浄化部としてのダイアライザ2が接続された血液回路1を取り付け可能とされるとともに、ダイアライザ2に透析液を供給しつつ除水する透析装置本体6と、透析装置本体6に配設された制御部16、再循環検出部17及び表示部18とを有して構成されている。
Hereinafter, an embodiment of the present invention will be described in detail with reference to the drawings.
The blood purification device according to this embodiment purifies a patient's blood while circulating it extracorporeally, and is applied to a hemodialysis device used in hemodialysis treatment. As shown in Fig. 1, this hemodialysis device is capable of mounting a blood circuit 1 connected to a dialyzer 2 as a blood purification unit, and is configured to include a dialysis device main body 6 that supplies dialysate to the dialyzer 2 while removing water from the dialyzer 2, a control unit 16, a recirculation detection unit 17, and a display unit 18 disposed in the dialysis device main body 6.

 血液回路1は、同図に示すように、可撓性チューブから成る動脈側血液回路1a及び静脈側血液回路1bから主に構成されており、これら動脈側血液回路1aと静脈側血液回路1bの間にダイアライザ2が接続されている。動脈側血液回路1aには、その先端に動脈側穿刺針aが接続されているとともに、途中にしごき型の血液ポンプ3、除泡用のエアトラップチャンバ4a及び第1検出部5aが配設されている。一方、静脈側血液回路1bには、その先端に静脈側穿刺針bが接続されているとともに、途中に第2検出部5b及び除泡用のエアトラップチャンバ4bが接続されている。 As shown in the diagram, the blood circuit 1 is primarily composed of an arterial blood circuit 1a and a venous blood circuit 1b, each made of flexible tubes, with a dialyzer 2 connected between the arterial blood circuit 1a and the venous blood circuit 1b. An arterial puncture needle a is connected to the tip of the arterial blood circuit 1a, and a peristaltic blood pump 3, a debubbling air trap chamber 4a, and a first detection unit 5a are disposed along the way. Meanwhile, a venous puncture needle b is connected to the tip of the venous blood circuit 1b, and a second detection unit 5b and a debubbling air trap chamber 4b are connected along the way.

 そして、動脈側穿刺針a及び静脈側穿刺針bを患者に穿刺した状態で、血液ポンプ3を駆動させると、患者の血液は、エアトラップチャンバ4aで除泡がなされつつ動脈側血液回路1aを通ってダイアライザ2に至り、ダイアライザ2によって血液浄化が施された後、エアトラップチャンバ4bで除泡がなされつつ静脈側血液回路1bを通って患者の体内に戻る。これにより、患者の血液を血液回路1にて体外循環させつつダイアライザ2にて浄化することができる。 Then, when the blood pump 3 is driven with the arterial puncture needle a and the venous puncture needle b inserted into the patient, the patient's blood passes through the arterial blood circuit 1a and reaches the dialyzer 2 while being debubbled in the air trap chamber 4a. After being purified by the dialyzer 2, the patient's blood passes through the venous blood circuit 1b while being debubbled in the air trap chamber 4b and returns to the patient's body. In this way, the patient's blood can be circulated extracorporeally through the blood circuit 1 while being purified by the dialyzer 2.

 ダイアライザ2は、その筐体部に、血液導入ポート2a、血液導出ポート2b、透析液導入ポート2c及び透析液導出ポート2dが形成されており、このうち血液導入ポート2aには動脈側血液回路1aの基端が、血液導出ポート2bには静脈側血液回路1bの基端がそれぞれ接続されている。また、透析液導入ポート2c及び透析液導出ポート2dは、透析装置本体6から延設された透析液導入ライン7及び透析液排出ライン8とそれぞれ接続されている。 The dialyzer 2 has a blood inlet port 2a, a blood outlet port 2b, a dialysate inlet port 2c, and a dialysate outlet port 2d formed in its housing. Of these, the blood inlet port 2a is connected to the base end of the arterial blood circuit 1a, and the blood outlet port 2b is connected to the base end of the venous blood circuit 1b. The dialysate inlet port 2c and dialysate outlet port 2d are connected to a dialysate inlet line 7 and a dialysate outlet line 8, respectively, which extend from the dialysis device main body 6.

 ダイアライザ2内には、複数の中空糸が収容されており、中空糸の内部が血液の流路とされるとともに、中空糸の外周面と筐体部の内周面との間が透析液の流路とされている。中空糸には、その外周面と内周面とを貫通した微少な孔(ポア)が多数形成されて中空糸膜を形成しており、この中空糸膜を介して血液中の不純物等が透析液内に透過し得るよう構成されている。 The dialyzer 2 contains multiple hollow fibers, the interior of which serves as a blood flow path, and the space between the outer circumferential surface of the hollow fibers and the inner circumferential surface of the housing serves as a dialysate flow path. The hollow fibers have numerous tiny pores that penetrate from their outer circumferential surface to their inner circumferential surface, forming hollow fiber membranes that allow impurities in the blood to pass through into the dialysate.

 一方、透析装置本体6は、複式ポンプCと、透析液排出ライン8において複式ポンプCの排液側Cbを迂回して接続されたバイパスライン9と、該バイパスライン9に接続された除水ポンプ10と、ダイアライザ2から複式ポンプCの排液側Cbへ透析液を流動させる加圧ポンプ11と、気泡分離チャンバ12と、大気開放ライン13と、電磁弁14とを有して構成されている。 Meanwhile, the dialysis device main body 6 is composed of a duplex pump C, a bypass line 9 connected to the dialysate discharge line 8, bypassing the drain side Cb of the duplex pump C, a water removal pump 10 connected to the bypass line 9, a pressure pump 11 that flows the dialysate from the dialyzer 2 to the drain side Cb of the duplex pump C, a bubble separation chamber 12, an atmospheric vent line 13, and a solenoid valve 14.

 複式ポンプCは、透析液導入ライン7及び透析液排出ライン8に跨って配設され、透析液導入ライン7からダイアライザ2に対して透析液を導入させるとともに、ダイアライザ2に導入された透析液を透析液排出ライン8から排出させるためのものである。すなわち、複式ポンプCは、供給側Caと排液側Cbとが略等量とされた定量型のポンプから成り、供給側Paから排液側Pbまでの透析液の流路(具体的には、透析液導入ライン7における複式ポンプCの下流側の流路、透析液排出ライン8における複式ポンプCの上流側の流路、及びダイアライザ2の透析液流路)は、電磁弁14が閉じた状態で、閉鎖系流路(密閉が保たれた状態の流路)が形成されている。 The duplex pump C is disposed across the dialysate inlet line 7 and the dialysate outlet line 8, and serves to introduce dialysate from the dialysate inlet line 7 to the dialyzer 2 and to discharge the dialysate introduced into the dialyzer 2 from the dialysate outlet line 8. Specifically, the duplex pump C is a metering pump with approximately equal volumes on the supply side Ca and the drain side Cb, and the dialysate flow path from the supply side Pa to the drain side Pb (specifically, the flow path downstream of the duplex pump C in the dialysate inlet line 7, the flow path upstream of the duplex pump C in the dialysate outlet line 8, and the dialysate flow path of the dialyzer 2) forms a closed flow path (a flow path that remains sealed) when the solenoid valve 14 is closed.

 加圧ポンプ11は、透析液排出ライン8におけるダイアライザ2と複式ポンプCとの間に接続され、ダイアライザ2から複式ポンプCへ透析液を流動させるためのものであり、遠心型のように非容積型ポンプ(圧力制御型)から成るものである。なお、後述する除水ポンプ10も、加圧ポンプ11と同様、遠心型のように非容積型ポンプ(圧力制御型)から成るものとされている。 The pressure pump 11 is connected between the dialyzer 2 and the duplex pump C in the dialysate discharge line 8, and is used to flow the dialysate from the dialyzer 2 to the duplex pump C. It is a non-positive displacement pump (pressure-controlled type) such as a centrifugal type. The water removal pump 10, which will be described later, is also a non-positive displacement pump (pressure-controlled type) such as a centrifugal type, just like the pressure pump 11.

 そして、透析液導入ライン7の一端がダイアライザ2の透析液導入ポート2cに接続されるとともに、他端が所定濃度の透析液を調製する透析液供給装置(不図示)に接続されている。また、透析液排出ライン8の一端は、ダイアライザ2の透析液導出ポート2dに接続されるとともに、他端が図示しない排液手段(不図示)と接続されており、透析液供給装置から供給された透析液が透析液導入ライン7を通ってダイアライザ2に至った後、透析液排出ライン8及びバイパスライン9を通って排液手段に送られるようになっている。 One end of the dialysate inlet line 7 is connected to the dialysate inlet port 2c of the dialyzer 2, and the other end is connected to a dialysate supply device (not shown) that prepares dialysate of a predetermined concentration. Furthermore, one end of the dialysate outlet line 8 is connected to the dialysate outlet port 2d of the dialyzer 2, and the other end is connected to a drainage means (not shown). After the dialysate supplied from the dialysate supply device reaches the dialyzer 2 through the dialysate inlet line 7, it is sent to the drainage means through the dialysate outlet line 8 and bypass line 9.

 除水ポンプ10は、ダイアライザ2を流れる患者の血液から水分を除去するためのものである。すなわち、除水ポンプ10を駆動させると、複式ポンプCが定量型であるため、透析液導入ライン7から導入される透析液量よりも透析液排出ライン8から排出される液体の容量が多くなり、その多い容量分だけ血液中から水分が除去されるのである。 The ultrafiltration pump 10 is used to remove water from the patient's blood flowing through the dialyzer 2. In other words, because the duplex pump C is a fixed-volume type, when the ultrafiltration pump 10 is driven, the volume of liquid discharged from the dialysate discharge line 8 is greater than the volume of dialysate introduced from the dialysate inlet line 7, and water is removed from the blood in an amount equal to the greater volume.

 気泡分離チャンバ12は、所謂脱ガスチャンバと呼ばれるもので、透析液排出ライン8における加圧ポンプ11と複式ポンプCとの間に接続された所定容量のものから成り、透析液中の気泡を捕捉し得るよう構成されたものである。この気泡分離チャンバ12からは、既述したバイパスライン9が延設されているとともに、大気開放ライン13が延設されている。この大気開放ライン13は、先端が大気開放とされており、その途中には弁手段としての電磁弁14が接続されている。 The bubble separation chamber 12 is what is commonly called a degassing chamber, and is of a specified capacity connected between the pressure pump 11 and the duplex pump C in the dialysis fluid discharge line 8, and is configured to capture bubbles in the dialysis fluid. Extending from this bubble separation chamber 12 are the bypass line 9 mentioned above, as well as an atmosphere vent line 13. The tip of this atmosphere vent line 13 is open to the atmosphere, and a solenoid valve 14 serving as a valve means is connected midway through the line.

 電磁弁14は、大気開放ライン13を開放又は閉止するために開閉可能とされたもので、開放状態で気泡分離チャンバ12が外気と連通し、閉止状態で気泡分離チャンバ12が外気と遮断するようになっている。そして、透析治療前又は透析治療後において、電磁弁14を操作して大気開放ライン13を開放させることにより、気泡分離チャンバ12内に捕捉された気泡を大気に放出させることができる。 The solenoid valve 14 can be opened and closed to open or close the atmosphere release line 13. When open, the bubble separation chamber 12 is in communication with the outside air, and when closed, the bubble separation chamber 12 is isolated from the outside air. Before or after dialysis treatment, the solenoid valve 14 can be operated to open the atmosphere release line 13, allowing the bubbles trapped in the bubble separation chamber 12 to be released into the atmosphere.

 また、本実施形態に係る透析液導入ライン7には、供給ラインLaが接続されている。かかる供給ラインLaは、血液回路1に補液としての透析液を供給可能とされており、その基端が透析液導入ライン7における複式ポンプCの供給側Caとダイアライザ2の透析液導入ポート2cとの間の部位に接続されるとともに、先端が前補液用供給ラインLa1及び後補液用供給ラインLa2に分岐し、動脈側血液回路1aのエアトラップチャンバ4a及び静脈側血液回路1bのエアトラップチャンバ4bにそれぞれ接続されている。 In addition, a supply line La is connected to the dialysate introduction line 7 in this embodiment. This supply line La is capable of supplying dialysate as a replacement fluid to the blood circuit 1, and its base end is connected to a portion of the dialysate introduction line 7 between the supply side Ca of the duplex pump C and the dialysate introduction port 2c of the dialyzer 2, while its tip branches into a pre-replacement fluid supply line La1 and a post-replacement fluid supply line La2, which are connected to the air trap chamber 4a of the arterial blood circuit 1a and the air trap chamber 4b of the venous blood circuit 1b, respectively.

 かかる供給ラインLaには、血液ポンプ3と同様のしごき型ポンプから成る補液ポンプ15が配設されており、血液浄化治療の過程において、補液ポンプ15を駆動させることにより、透析液導入ライン7の透析液が前補液用供給ラインLa1を介して動脈側血液回路1aに供給されて前補液可能とされるとともに、後補液用供給ラインLa2を介して静脈側血液回路1bに供給されて後補液可能とされている。 A fluid replacement pump 15, which is a peristaltic pump similar to the blood pump 3, is provided on this supply line La. During blood purification treatment, by driving the fluid replacement pump 15, the dialysate in the dialysate introduction line 7 is supplied to the arterial blood circuit 1a via the pre-fluid replacement supply line La1, enabling pre-fluid replacement, and to the venous blood circuit 1b via the post-fluid replacement supply line La2, enabling post-fluid replacement.

 ここで、本実施形態における大気開放ライン13及び電磁弁14は、本発明の特性変化付与部を構成しており、電磁弁14を操作して大気開放ライン13を開放させることにより、ダイアライザ2を流れる血液に対し急激で且つ短時間の濃縮を行って特有のピークが形成された局所的な濃度変化(特性変化)を付与し得るようになっている。すなわち、透析治療中において、電磁弁14を操作して閉止状態の大気開放ライン13を開放すると、加圧ポンプ11の出口圧が大気圧と略等しくなることから、加圧ポンプ11の上流側では瞬間的に高い陰圧が発生し、ダイアライザ2(血液の流路)を流れる血液に対して、急激で且つ短時間の除水(血液濃縮)が行われるのである。 In this embodiment, the atmosphere vent line 13 and solenoid valve 14 constitute the characteristic change imparting unit of the present invention, and by operating the solenoid valve 14 to open the atmosphere vent line 13, a local concentration change (characteristic change) with a unique peak can be imparted to the blood flowing through the dialyzer 2 by rapid and short-term concentration. In other words, during dialysis treatment, when the solenoid valve 14 is operated to open the closed atmosphere vent line 13, the outlet pressure of the pressure pump 11 becomes approximately equal to atmospheric pressure, and a momentary high negative pressure is generated upstream of the pressure pump 11, causing rapid and short-term water removal (hemoconcentration) of the blood flowing through the dialyzer 2 (blood flow path).

 これにより、除水ポンプ10の駆動により発生する限外濾過圧よりも遙かに大きく、且つ短時間で血液に対して大量の除水を行うことができ、血液濃度(ヘマトクリット値)の変化に特有のピークを付与することができる。なお、電磁弁14による大気開放ライン13の開放は、短時間(本実施形態においては、大気開放ライン13の開放は、10秒以下の任意の時間を設定することができ、1秒でも十分な測定精度を有する)で行われ、すぐに電磁弁14を操作することにより大気開放ライン13が閉止されることとなる。 This allows a large amount of water to be removed from the blood in a short time at a pressure far greater than the ultrafiltration pressure generated by driving the water removal pump 10, and creates a unique peak in the change in blood concentration (hematocrit value). The solenoid valve 14 opens the atmosphere vent line 13 for a short time (in this embodiment, the opening of the atmosphere vent line 13 can be set to any time less than 10 seconds, and even 1 second provides sufficient measurement accuracy), and the solenoid valve 14 is immediately operated to close the atmosphere vent line 13.

 この電磁弁14による大気開放ライン13の開放時間は、血液濃度情報(患者の血液濃度に関する情報)や圧力情報(静脈圧や透析液圧など)に基づき、自動的に最適となるよう制御されるのが好ましい。しかるに、本発明における「急激且つ短時間」とは、回路を経た後において付与したパルスが確認できる程度の大きさ及び時間のことをいい、「特有」とは、ポンプの変動や患者の体動による他の要因による変動パターンと区別できるものをいう。 The time that the solenoid valve 14 opens the atmospheric vent line 13 is preferably automatically controlled to be optimal based on blood concentration information (information about the patient's blood concentration) and pressure information (venous pressure, dialysis fluid pressure, etc.). In this invention, "sudden and short-term" refers to a magnitude and duration that allows the applied pulse to be confirmed after passing through the circuit, and "unique" refers to a fluctuation pattern that can be distinguished from fluctuations caused by other factors such as pump fluctuations or patient movement.

 第1検出部5a及び第2検出部5bは、動脈側血液回路1a及び静脈側血液回路1bにそれぞれ配設されて、これら流路を流れる血液の濃度(具体的にはヘマトクリット値)を検出するものである。かかる第1検出部5a及び第2検出部5bは、例えばLED等の発光素子及びフォトダイオード等の受光素子を備えたヘマトクリットセンサから成るもので、発光素子から血液に光を照射するとともに、その透過した光或いは反射した光を受光素子にて受光することにより、患者の血液濃度を示すヘマトクリット値を検出するよう構成されている。 The first and second detectors 5a and 5b are disposed in the arterial and venous blood circuits 1a and 1b, respectively, and detect the concentration (specifically, the hematocrit value) of the blood flowing through these channels. The first and second detectors 5a and 5b are composed of hematocrit sensors equipped with a light-emitting element such as an LED and a light-receiving element such as a photodiode, and are configured to detect the hematocrit value, which indicates the concentration of the patient's blood, by irradiating light onto the blood from the light-emitting element and receiving the transmitted or reflected light with the light-receiving element.

 具体的には、第1検出部5a及び第2検出部5bは、受光素子から出力された電気信号に基づき、血液の濃度を示すヘマトクリット値を求める。すなわち、血液を構成する赤血球や血漿などの各成分は、それぞれ固有の吸光特性を持っており、この性質を利用してヘマトクリット値を測定するのに必要な赤血球を電子光学的に定量化することにより当該ヘマトクリット値を求めることができるのである。しかるに、発光素子から照射された近赤外線は、血液に入射して吸収と散乱の影響を受け、受光素子にて受光されるとともに、その受光した光の強弱から光の吸収散乱率を解析することにより、ヘマトクリット値が算出されることとなる。 Specifically, the first detection unit 5a and the second detection unit 5b determine the hematocrit value, which indicates the blood concentration, based on the electrical signal output from the light-receiving element. Each component of blood, such as red blood cells and plasma, has its own unique light absorption characteristics, and this property can be used to electro-optically quantify the red blood cells required to measure the hematocrit value, thereby determining the hematocrit value. However, near-infrared light emitted from the light-emitting element is affected by absorption and scattering when it enters the blood and is received by the light-receiving element. The hematocrit value can then be calculated by analyzing the light absorption and scattering rate from the intensity of the received light.

 上記の如く構成された第1検出部5aは、動脈側血液回路1aに配設されているので、透析治療中における動脈側穿刺針aを介して患者から採取した血液のヘマトクリット値を検出するとともに、第2検出部5bは、静脈側血液回路1bに配設されているので、ダイアライザ2にて浄化され、患者に戻される血液のヘマトクリット値を検出することとなる。そして、電磁弁14を開放させることにより局所的な濃度変化を付与すると、図4に示すように、第2検出部5bで特有のピークP1が形成された局所的な濃度変化αが検出されるとともに、その血液が再び動脈側血液回路1aに至って再循環があった場合、当該再循環血液に残存し、特有のピークP2が形成された局所的な濃度変化βが第1検出部5aで検出されるようになっている。 The first detector 5a configured as described above is disposed in the arterial blood circuit 1a and detects the hematocrit value of blood collected from the patient via the arterial puncture needle a during dialysis treatment. The second detector 5b is disposed in the venous blood circuit 1b and detects the hematocrit value of blood purified by the dialyzer 2 and returned to the patient. When a local concentration change is introduced by opening the solenoid valve 14, the second detector 5b detects a local concentration change α with a characteristic peak P1, as shown in Figure 4. If the blood returns to the arterial blood circuit 1a and is recirculated, the first detector 5a detects a local concentration change β that remains in the recirculated blood and forms a characteristic peak P2.

 制御部16は、例えばマイコン等で構成されたものであり、図2に示すように、ダイアライザ2(血液浄化部)に透析液を導入及び導出する複式ポンプC、血液回路1に配設された血液ポンプ3、血液回路1を体外循環する血液から除水するための除水ポンプ10、加圧ポンプ11、血液回路に補液(透析液)を導入する補液ポンプ15、血液回路1にヘパリン等の薬液を注入するための薬液注入ポンプ(不図示)等のポンプ、並びに血液の濃度変化に特有のピークが形成された局所的な濃度変化を付与し得る電磁弁14等の電磁弁と電気的に接続され、これらポンプ及び電磁弁を制御可能とされている。 The control unit 16 is composed of, for example, a microcomputer, and as shown in FIG. 2, is electrically connected to pumps such as a duplex pump C that introduces and extracts dialysate to the dialyzer 2 (blood purification unit), a blood pump 3 arranged in the blood circuit 1, a water removal pump 10 that removes water from the blood circulating extracorporeally through the blood circuit 1, a pressure pump 11, a replacement fluid pump 15 that introduces replacement fluid (dialysis fluid) into the blood circuit, and a drug injection pump (not shown) that injects drug solutions such as heparin into the blood circuit 1, as well as solenoid valves such as solenoid valve 14 that can impart localized concentration changes that form peaks specific to changes in blood concentration, and is capable of controlling these pumps and solenoid valves.

 また、本実施形態に係る制御部16は、図2に示すように、指示入力部SW2と接続されており、操作者が指示入力部SW2を操作することにより指示入力可能とされている。かかる指示入力部SW2は、操作者が任意のタイミングで操作して入力可能なものであればよく、例えばタッチパネル(表示部18含む)に表示されたスイッチ部、或いは機械的なスイッチであってもよい。 Furthermore, as shown in FIG. 2, the control unit 16 according to this embodiment is connected to an instruction input unit SW2, and an operator can input instructions by operating the instruction input unit SW2. Such instruction input unit SW2 may be any unit that can be operated by the operator at any timing to input instructions, and may be, for example, a switch unit displayed on a touch panel (including the display unit 18), or a mechanical switch.

 さらに、本実施形態に係る第1検出部5a及び第2検出部5bは、透析装置本体6に配設された再循環検出部17と電気的に接続されるとともに、再循環検出部17はタッチパネルで構成された表示部18と電気的に接続されている。表示部18は、第1検出部5a及び第2検出部5bで検出された局所的な濃度変化α、βをグラフ表示するもので、当該グラフ表示に加えて、再循環検出部17で算出された再循環血液の比率等を数値等で表示可能とされている。 Furthermore, the first detection unit 5a and second detection unit 5b in this embodiment are electrically connected to a recirculation detection unit 17 arranged in the dialysis device main body 6, and the recirculation detection unit 17 is electrically connected to a display unit 18 consisting of a touch panel. The display unit 18 displays a graph of the local concentration changes α and β detected by the first detection unit 5a and second detection unit 5b, and in addition to this graph display, it is also capable of displaying the ratio of recirculated blood calculated by the recirculation detection unit 17 as a numerical value, etc.

 また、本実施形態に係る表示部18は、図2に示すように、切替入力部SW1と接続されており、操作者が切替入力部SW1を操作することにより切替入力可能とされている。かかる指示入力部SW2は、操作者が任意のタイミングで操作して入力可能なものであればよく、例えばタッチパネル(表示部18含む)に表示されたスイッチ部、或いは機械的なスイッチであってもよい。 Furthermore, as shown in FIG. 2, the display unit 18 according to this embodiment is connected to the switching input unit SW1, and can be switched and input by the operator operating the switching input unit SW1. Such instruction input unit SW2 can be anything that the operator can operate and input at any time, and may be, for example, a switch unit displayed on a touch panel (including the display unit 18), or a mechanical switch.

 再循環検出部17は、例えばマイコン等で構成されたものであり、第1検出部5aで検出された局所的な濃度変化βと第2検出部5bで検出された局所的な濃度変化αとに基づいて、静脈側血液回路1bから患者に戻された血液が再び動脈側血液回路1aに導かれて流れる再循環血液を検出し、再循環血液の比率(再循環率)を算出可能なものである。本実施形態に係る再循環検出部17は、図3に示すように、監視部17aと、グラフ作成部17bと、演算部17cと、メモリ部17dとを有して構成されている。 The recirculation detection unit 17 is configured, for example, by a microcomputer, and is capable of detecting recirculated blood, which is blood returned to the patient from the venous blood circuit 1b and then guided back into the arterial blood circuit 1a, based on the local concentration change β detected by the first detection unit 5a and the local concentration change α detected by the second detection unit 5b, and calculating the proportion of recirculated blood (recirculation rate). As shown in Figure 3, the recirculation detection unit 17 in this embodiment is configured to include a monitoring unit 17a, a graph creation unit 17b, a calculation unit 17c, and a memory unit 17d.

 監視部17aは、第1検出部5a及び第2検出部5bで検出された血液の濃度変化を血液浄化治療中において経時的に監視するものである。そして、グラフ作成部17bは、監視部17aで経時的に監視した血液の濃度変化に基づいて、局所的な濃度変化α、βを示すグラフを作成するとともに、演算部17cは、グラフ作成部17bで作成されたグラフに基づいて再循環血液の割合(再循環率)を求めるようになっている。また、監視部17aで監視された血液の濃度変化、グラフ作成部17bで作成されたグラフ、演算部17cで求められた再循環血液の割合(再循環率)は、メモリ部17dにて記憶されることとなる。 The monitoring unit 17a monitors changes in blood concentration detected by the first detection unit 5a and the second detection unit 5b over time during blood purification treatment. The graph creation unit 17b creates a graph showing local concentration changes α and β based on the changes in blood concentration monitored over time by the monitoring unit 17a, and the calculation unit 17c calculates the proportion of recirculated blood (recirculation rate) based on the graph created by the graph creation unit 17b. The changes in blood concentration monitored by the monitoring unit 17a, the graph created by the graph creation unit 17b, and the proportion of recirculated blood (recirculation rate) calculated by the calculation unit 17c are stored in the memory unit 17d.

 具体的には、再循環検出部17は、図4で示すような横軸を経過時間(積算流量又は時間)及び縦軸を血液濃度(ヘマトクリット値)としたグラフに基づき、第1検出部5a及び第2検出部5bのヘマトクリット値の変化(濃度変化)を求め、特有のピークP1が形成された局所的な濃度変化αの面積S1と、特有のピークP2が形成された局所的な濃度変化βの面積S2とを積分法など数学的手法にて演算する。そして、再循環血液の割合(再循環率)Rrecは、以下の如き演算式にて求められる。 Specifically, the recirculation detection unit 17 determines the change in hematocrit value (concentration change) of the first detection unit 5a and the second detection unit 5b based on a graph such as that shown in Figure 4, with the horizontal axis representing elapsed time (cumulative flow rate or time) and the vertical axis representing blood concentration (hematocrit value), and calculates the area S1 of the local concentration change α where characteristic peak P1 is formed and the area S2 of the local concentration change β where characteristic peak P2 is formed using a mathematical method such as integration. The proportion of recirculated blood (recirculation rate) Rrec can then be calculated using the following formula:

 Rrec(%)=S2/S1×100 Rrec (%)=S2/S1×100

 このように求められた再循環血液の割合(再循環率)Rrecは、表示部18にて表示され、医師等医療従事者が視認し得るようになっている。なお、血液再循環がない場合は、上記S2が0となるため、再循環血液の割合として表示される数値は0(%)となる。さらに、本実施形態に係る表示部18は、再循環率に加え、図4のように、第1検出部5a及び第2検出部5bで検出された局所的な濃度変化をグラフ表示可能とされており、特有のピークP1が形成された局所的な濃度変化α及び特有のピークP2が形成された局所的な濃度変化βをそれぞれ曲線のグラフとして表示し得るようになっている。 The proportion of recirculated blood (recirculation rate) Rrec calculated in this manner is displayed on the display unit 18 so that it can be visually confirmed by doctors and other medical professionals. If there is no blood recirculation, the above S2 will be 0, and the value displayed as the proportion of recirculated blood will be 0 (%). Furthermore, in addition to the recirculation rate, the display unit 18 in this embodiment is capable of graphically displaying the local concentration changes detected by the first detection unit 5a and the second detection unit 5b, as shown in Figure 4, and is able to display the local concentration change α where the characteristic peak P1 is formed and the local concentration change β where the characteristic peak P2 is formed, each as a curve graph.

 一方、再循環検出部17は、第1検出部5a及び第2検出部5bで検出された血液濃度に基づいて、図4に示すように、横軸を経過時間(積算流量又は時間)及び縦軸を血液濃度(ヘマトクリット値)とした局所的な濃度変化α、βを示すグラフを作成するとともに、その血液濃度の変化を所定周期(例えば0.1s周期)で監視している。これにより、特有のピークP1が形成された局所的な濃度変化αの開始時点R1及び終了時点R2と、特有のピークP2が形成された局所的な濃度変化βの開始時点W1及び終了時点W2とを検出することができ、局所的な濃度変化αの面積S1と局所的な濃度変化βの面積S2とを精度よく演算し得るようになっている。 Meanwhile, the recirculation detection unit 17 creates a graph showing local concentration changes α and β, with the horizontal axis representing elapsed time (cumulative flow rate or time) and the vertical axis representing blood concentration (hematocrit value), as shown in Figure 4, based on the blood concentration detected by the first detection unit 5a and the second detection unit 5b, and monitors the changes in blood concentration at a predetermined interval (e.g., 0.1 second interval). This makes it possible to detect the start time R1 and end time R2 of the local concentration change α at which the characteristic peak P1 is formed, and the start time W1 and end time W2 of the local concentration change β at which the characteristic peak P2 is formed, and to accurately calculate the area S1 of the local concentration change α and the area S2 of the local concentration change β.

 ここで、本実施形態に係る再循環検出部17は、図7に示すように、局所的な濃度変化αが検出される直前に検出されるノイズ波形γを検出するとともに、ノイズ波形γに基づいて局所的な濃度変化αの開始時点R1を特定するよう構成されている。かかるノイズ波形γは、特性変化付与部を構成する電磁弁14を閉状態から開状態として局所的な濃度変化を付与した場合、第2検出部5bで検出される局所的な濃度変化αの前兆ノイズとして発生するものである。 As shown in FIG. 7, the recirculation detection unit 17 according to this embodiment is configured to detect a noise waveform γ detected immediately before a local concentration change α is detected, and to identify the start time point R1 of the local concentration change α based on the noise waveform γ. This noise waveform γ is generated as a precursor noise of the local concentration change α detected by the second detection unit 5b when the solenoid valve 14 constituting the characteristic change imparting unit is changed from a closed state to an open state to impart a local concentration change.

 具体的には、再循環検出部17は、ノイズ波形γのピークP3を検出した後、濃度変化が減少から増加に変化した時点を局所的な濃度変化αの開始時点R1として特定するものとされている。例えば、所定の周期毎に検出された血液濃度の値の最大値または最小値を逐次更新し、最大値から血液濃度の値が減少した時点において濃度変化が減少し、最小値から血液濃度の値が増加した時点において濃度変化が増加したとされる。 Specifically, after detecting peak P3 of the noise waveform γ, the recirculation detection unit 17 identifies the point in time when the concentration change changes from a decrease to an increase as the start point R1 of the local concentration change α. For example, the maximum or minimum value of the detected blood concentration value is updated sequentially at each predetermined cycle, and the concentration change is considered to have decreased when the blood concentration value decreases from the maximum value, and to have increased when the blood concentration value increases from the minimum value.

 また、例えば、再循環検出部17は、時間経過または血液の積算流量に伴う濃度変化を示すグラフにおける所定周期毎の傾きまたは面積を逐次検出するとともに、その検出された傾きの変化または面積の変化に基づいて濃度変化の減少(グラフ中右下がり傾向)及び増加(グラフ中右上がり傾向)を検出することができる。 Furthermore, for example, the recirculation detection unit 17 can sequentially detect the slope or area for each predetermined period in a graph showing changes in concentration over time or with the cumulative blood flow rate, and can detect decreases (a downward trend to the right in the graph) and increases (an upward trend to the right in the graph) in concentration changes based on the detected changes in slope or area.

 なお、グラフ中の波形のピーク(局所的な濃度変化αの特有のピークP1、局所的な濃度変化βの特有のピークP2、及びノイズ波形γのピークP3)は、各波形の最大値を算出することにより求めることができる。また、所定周期毎の傾きは、周期内の曲線に対して最小二乗法等の演算方法を用いて求めることができるとともに、所定周期毎の面積は、周期内の曲線に対して積分法等の演算方法を用いて求めることができる。 The peaks of the waveforms in the graph (peak P1 characteristic of local concentration change α, peak P2 characteristic of local concentration change β, and peak P3 of noise waveform γ) can be found by calculating the maximum value of each waveform. The slope for each predetermined cycle can be found using a calculation method such as the least squares method for the curve within the cycle, and the area for each predetermined cycle can be found using a calculation method such as integration for the curve within the cycle.

 しかるに、本実施形態においては、再循環検出部17により再循環血液を検出して再循環血液の比率を算出する工程は、血液浄化治療が行われる治療工程とは別の測定工程にて行われる。かかる測定工程時においては、制御部16は、制御対象のポンプ(複式ポンプC、血液ポンプ3、除水ポンプ10、加圧ポンプ11、補液ポンプ15、薬液注入ポンプ等)を駆動するためのパラメータを血液浄化治療が行われる治療工程時とは異なる測定用パラメータに変更して制御するようになっている。かかる測定工程について、図5のフローチャートに基づいて説明する。 However, in this embodiment, the process of detecting recirculated blood using the recirculation detection unit 17 and calculating the proportion of recirculated blood is performed in a measurement process separate from the treatment process in which blood purification treatment is performed. During this measurement process, the control unit 16 changes the parameters for driving the pumps to be controlled (duplex pump C, blood pump 3, water removal pump 10, pressure pump 11, fluid replacement pump 15, drug injection pump, etc.) to measurement parameters that are different from those used during the treatment process in which blood purification treatment is performed. This measurement process will be explained based on the flowchart in Figure 5.

 まず、操作者による切替入力部SW1の入力操作を条件として測定工程が開始されると、S1にて制御部16によって制御対象のポンプを測定用パラメータに一時変更し、その測定パラメータに基づいて当該ポンプを駆動させた後、S2にて第1検出部5a及び第2検出部5bで検出される血液濃度が安定状態になるまで待機する。かかる測定用パラメータは、ポンプ(制御対象のポンプ)の駆動速度を治療工程時より低下または停止させるパラメータから成る。そして、第1検出部5a及び第2検出部5bで検出される血液濃度が安定状態になった後、操作者による指示入力部SW2の入力操作を条件として、S3に進み、電磁弁14を操作して大気開放ライン13を開放させることにより、特有のピークP1、P2が形成された局所的な濃度変化を付与する。 First, the measurement process begins upon input operation of the switch input unit SW1 by the operator. In S1, the control unit 16 temporarily changes the pump to be controlled to the measurement parameters and drives the pump based on those measurement parameters. Then, in S2, the system waits until the blood concentration detected by the first detection unit 5a and the second detection unit 5b stabilizes. These measurement parameters consist of parameters that slow the drive speed of the pump (the pump to be controlled) down from that during the treatment process or stop the pump. Then, upon input operation of the command input unit SW2 by the operator, the system proceeds to S3, where the solenoid valve 14 is operated to open the atmosphere vent line 13, thereby creating localized concentration changes with characteristic peaks P1 and P2.

 その後、S4に進み、第1検出部5aで検出された局所的な濃度変化αと、第2検出部5bで検出された局所的な濃度変化βとに基づいて、再循環検出部17が再循環血液を検出し、再循環血液の比率(再循環率)を算出する。なお、算出された再循環血液の比率(再循環率)は、表示部18にて表示され、医師等医療従事者による対応を促すようになっている。そして、再循環血液の検出及び再循環血液の比率(再循環率)が算出された後、操作者による切替入力部SW1の入力操作を条件として、S5に進み、制御部16によって測定パラメータから治療用パラメータに復帰する。これにより、測定工程が終了し、治療用パラメータに基づいて血液浄化治療を行わせることができる。 Then, the process proceeds to S4, where the recirculation detection unit 17 detects recirculated blood and calculates the proportion of recirculated blood (recirculation rate) based on the local concentration change α detected by the first detection unit 5a and the local concentration change β detected by the second detection unit 5b. The calculated proportion of recirculated blood (recirculation rate) is displayed on the display unit 18 to prompt a medical professional such as a doctor to take action. Then, after the recirculated blood has been detected and the proportion of recirculated blood (recirculation rate) calculated, the process proceeds to S5, where the control unit 16 reverts from measurement parameters to treatment parameters, provided that the operator operates the switch input unit SW1. This completes the measurement process, and blood purification treatment can be performed based on the treatment parameters.

 次に、上記測定工程の測定S4について、再循環検出部17による具体的制御内容を図6のフローチャートに基づいて説明する。
 図5のS3により局所的な濃度変化が付与された後、Sa1にて再循環検出部17によるノイズ波形γの検出が行われ、ノイズ波形γが検出されると、Sa2にてノイズ波形γの終端が検出される。かかるノイズ波形γの終端は、ノイズ波形γのピークP3を検出し、そのピークP3から濃度変化が減少から増加に変化した時点を検出することにより求めることができ、かかる終端を局所的な濃度変化αの開始時点R1とすることができる。
Next, the specific control contents of the recirculation detection unit 17 in the measurement S4 of the measurement step will be described with reference to the flowchart of FIG.
5, after the local concentration change is applied in S3, the recirculation detection unit 17 detects the noise waveform γ in Sa1, and when the noise waveform γ is detected, the end of the noise waveform γ is detected in Sa2. The end of the noise waveform γ can be found by detecting the peak P3 of the noise waveform γ and detecting the point in time from peak P3 when the concentration change changes from a decrease to an increase, and this end can be taken as the start point R1 of the local concentration change α.

 その後、Sa3に進み、特有のピークP1が形成された局所的な濃度変化αの開始時点R1及び終了時点R2と、特有のピークP2が形成された局所的な濃度変化βの開始時点W1及び終了時点W2とに基づいて、図4で示す面積S1及び面積S2を求め、これら面積S1、S2の割合から再循環血液の割合である再循環率(Rrec(%))を求めることができる。 Then, proceed to Sa3, and based on the start time R1 and end time R2 of the local concentration change α at which the characteristic peak P1 is formed, and the start time W1 and end time W2 of the local concentration change β at which the characteristic peak P2 is formed, the areas S1 and S2 shown in Figure 4 are calculated, and the recirculation rate (Rrec (%)), which is the proportion of recirculated blood, can be calculated from the ratio of these areas S1 and S2.

 本実施形態によれば、再循環検出部17は、局所的な濃度変化αが検出される直前に検出されるノイズ波形γを検出するとともに、ノイズ波形γに基づいて局所的な濃度変化αの開始時点R1を特定するので、ノイズ波形γを利用して、少なくとも局所的な濃度変化αの開始時点R1を精度よく検出することにより再循環血液の比率を高精度に算出することができる。 In this embodiment, the recirculation detection unit 17 detects the noise waveform γ that is detected immediately before the local concentration change α is detected, and identifies the start time R1 of the local concentration change α based on the noise waveform γ.Therefore, by using the noise waveform γ to accurately detect at least the start time R1 of the local concentration change α, the proportion of recirculated blood can be calculated with high accuracy.

 次に、本発明に係る第2の実施形態の血液浄化装置について説明する。
 本実施形態に係る血液浄化装置は、患者の血液を体外循環させつつ浄化するためのもので、血液透析治療で使用される血液透析装置に適用されたものである。かかる血液透析装置は、図1に示すように、血液浄化部としてのダイアライザ2が接続された血液回路1と、ダイアライザ2に透析液を供給しつつ除水する透析装置本体6と、透析装置本体6に配設された制御部16、再循環検出部17及び表示部18とを有して構成されている。なお、第1の実施形態と同様の構成要素には、同一の符号を付し、それらの詳細な説明を省略する。
Next, a blood purification apparatus according to a second embodiment of the present invention will be described.
The blood purification device according to this embodiment purifies a patient's blood while circulating it extracorporeally, and is applied to a hemodialysis device used in hemodialysis treatment. As shown in Fig. 1, this hemodialysis device comprises a blood circuit 1 connected to a dialyzer 2 as a blood purification unit, a dialysis device main body 6 that supplies dialysate to the dialyzer 2 while removing water from the dialyzer 2, and a control unit 16, a recirculation detection unit 17, and a display unit 18 disposed in the dialysis device main body 6. Note that the same components as those in the first embodiment are designated by the same reference numerals, and detailed descriptions thereof will be omitted.

 再循環検出部17は、第1の実施形態と同様、第1検出部5a及び第2検出部5bで検出された血液濃度に基づいて、図4に示すように、横軸を経過時間(積算流量又は時間)及び縦軸を血液濃度(ヘマトクリット値)とした局所的な濃度変化α、βを示すグラフを作成するとともに、その血液濃度の変化を所定周期(例えば0.1s周期)で監視している。これにより、特有のピークP1が形成された局所的な濃度変化αの開始時点R1及び終了時点R2と、特有のピークP2が形成された局所的な濃度変化βの開始時点W1及び終了時点W2とを検出することができ、局所的な濃度変化αの面積S1と局所的な濃度変化βの面積S2とを精度よく演算し得るようになっている。 As in the first embodiment, the recirculation detection unit 17 creates a graph showing local concentration changes α and β, with the horizontal axis representing elapsed time (cumulative flow rate or time) and the vertical axis representing blood concentration (hematocrit value), as shown in Figure 4, based on the blood concentration detected by the first detection unit 5a and the second detection unit 5b, and monitors the blood concentration changes at a predetermined interval (e.g., 0.1 second interval). This makes it possible to detect the start time R1 and end time R2 of the local concentration change α at which the characteristic peak P1 is formed, and the start time W1 and end time W2 of the local concentration change β at which the characteristic peak P2 is formed, and to accurately calculate the area S1 of the local concentration change α and the area S2 of the local concentration change β.

 ここで、本実施形態に係る再循環検出部17は、例えばマイコン等で構成されたものであり、第1検出部5aで検出された局所的な濃度変化βと第2検出部5bで検出された局所的な濃度変化αとに基づいて、静脈側血液回路1bから患者に戻された血液が再び動脈側血液回路1aに導かれて流れる再循環血液を検出し、再循環血液の比率(再循環率)を算出可能なものである。 The recirculation detection unit 17 in this embodiment is configured, for example, with a microcomputer, and is capable of detecting recirculated blood, which is blood returned to the patient from the venous blood circuit 1b and then guided back into the arterial blood circuit 1a, based on the local concentration change β detected by the first detection unit 5a and the local concentration change α detected by the second detection unit 5b, and calculating the proportion of recirculated blood (recirculation rate).

 特に、本実施形態に係る再循環検出部17は、図9に示すように、局所的な濃度変化αにおける特定のピークP1が検出された時点を基準として、局所的な濃度変化αの検出開始時に遡って順次検索(すなわち、図9中、特有のピークP1の時点からf方向に検索)し、濃度変化が減少から増加に変化した時点を局所的な濃度変化αの開始時点R1として特定するよう構成されている。 In particular, as shown in Figure 9, the recirculation detection unit 17 of this embodiment is configured to use the time when a specific peak P1 in the local concentration change α is detected as a reference point and sequentially search back to the start of detection of the local concentration change α (i.e., search in the direction f from the time of the specific peak P1 in Figure 9), and identify the time when the concentration change changes from a decrease to an increase as the start time R1 of the local concentration change α.

 なお、グラフ中の波形のピーク(局所的な濃度変化αの特有のピークP1、局所的な濃度変化βの特有のピークP2、及びノイズ波形γのピークP3)は、第1の実施形態と同様、各波形の最大値を算出することにより求めることができる。また、所定周期毎の傾きは、第1の実施形態と同様、周期内の曲線に対して最小二乗法等の演算方法を用いて求めることができるとともに、所定周期毎の面積は、周期内の曲線に対して積分法等の演算方法を用いて求めることができる。 Note that the waveform peaks in the graph (peak P1 characteristic of local concentration change α, peak P2 characteristic of local concentration change β, and peak P3 of noise waveform γ) can be found by calculating the maximum value of each waveform, as in the first embodiment. Also, the slope for each predetermined cycle can be found using a calculation method such as the least squares method for the curve within the cycle, as in the first embodiment, and the area for each predetermined cycle can be found using a calculation method such as integration for the curve within the cycle.

 しかるに、本実施形態においては、第1の実施形態と同様、再循環検出部17により再循環血液を検出して再循環血液の比率を算出する工程は、血液浄化治療が行われる治療工程とは別の測定工程にて行われる。かかる測定工程時においては、制御部16は、制御対象のポンプ(複式ポンプC、血液ポンプ3、除水ポンプ10、加圧ポンプ11、補液ポンプ15、薬液注入ポンプ等)を駆動するためのパラメータを血液浄化治療が行われる治療工程時とは異なる測定用パラメータに変更して制御するようになっている。かかる測定工程については、第1の実施形態において、図5のフローチャートに基づいて説明した通りである。 However, in this embodiment, as in the first embodiment, the process of detecting recirculated blood using the recirculation detection unit 17 and calculating the proportion of recirculated blood is performed in a measurement process separate from the treatment process in which blood purification treatment is performed. During this measurement process, the control unit 16 controls the pumps to be controlled (duplex pump C, blood pump 3, water removal pump 10, pressure pump 11, fluid replacement pump 15, drug injection pump, etc.) by changing the parameters for driving them to measurement parameters that are different from those used during the treatment process in which blood purification treatment is performed. This measurement process is as described in the first embodiment based on the flowchart in Figure 5.

 次に、上記測定工程の測定S4(図5参照)について、再循環検出部17による具体的制御内容を図8のフローチャートに基づいて説明する。
 図5のS3により局所的な濃度変化が付与された後、Sb1にて再循環検出部17による局所的な濃度変化αの特定のピークP1を検出する。そして、特定のピークP1が検出された後、Sb2に進み、その特定のピークP1が検出された時点を基準として、局所的な濃度変化αの検出開始時に遡って順次検索(f方向に順次検索)し、濃度変化が減少から増加に変化した時点を局所的な濃度変化αの開始時点R1とすることができる。
Next, the specific control contents by the recirculation detection unit 17 in the measurement S4 (see FIG. 5) of the measurement step will be described with reference to the flowchart of FIG.
5, after the local concentration change is given in S3, in Sb1, a specific peak P1 of the local concentration change α is detected by the recirculation detection unit 17. Then, after the specific peak P1 is detected, the process proceeds to Sb2, where, using the time point at which the specific peak P1 was detected as a reference, a sequential search is performed (sequential search in the direction f) going back to the start of detection of the local concentration change α, and the time point at which the concentration change changes from decreasing to increasing can be determined as the start time R1 of the local concentration change α.

 その後、Sb3に進み、特有のピークP1が形成された局所的な濃度変化αの開始時点R1及び終了時点R2と、特有のピークP2が形成された局所的な濃度変化βの開始時点W1及び終了時点W2とに基づいて、図4で示す面積S1及び面積S2を求め、これら面積S1、S2の割合から再循環血液の割合である再循環率(Rrec(%))を求めることができる。 Then, proceeding to Sb3, the areas S1 and S2 shown in Figure 4 are calculated based on the start time R1 and end time R2 of the local concentration change α at which the characteristic peak P1 is formed, and the start time W1 and end time W2 of the local concentration change β at which the characteristic peak P2 is formed, and the recirculation rate (Rrec (%)), which is the proportion of recirculated blood, can be calculated from the ratio of these areas S1 and S2.

 本実施形態によれば、再循環検出部17は、局所的な濃度変化αにおける特定のピークP1が検出された時点を基準として、局所的な濃度変化αの検出開始時に遡って順次検索し、濃度変化が減少から増加に変化した時点を局所的な濃度変化αの開始時点R1として特定するので、特定のピークP1を利用して、少なくとも局所的な濃度変化αの開始時点R1を精度よく検出することにより再循環血液の比率を高精度に算出することができる。 In this embodiment, the recirculation detection unit 17 uses the time when a specific peak P1 in the local concentration change α is detected as a reference point and sequentially searches back to the start of detection of the local concentration change α, identifying the time when the concentration change changes from a decrease to an increase as the start time R1 of the local concentration change α.Therefore, by using the specific peak P1 to accurately detect at least the start time R1 of the local concentration change α, the proportion of recirculated blood can be calculated with high precision.

 次に、本発明に係る第3の実施形態の血液浄化装置について説明する。
 本実施形態に係る血液浄化装置は、患者の血液を体外循環させつつ浄化するためのもので、血液透析治療で使用される血液透析装置に適用されたものである。かかる血液透析装置は、図1に示すように、血液浄化部としてのダイアライザ2が接続された血液回路1と、ダイアライザ2に透析液を供給しつつ除水する透析装置本体6と、透析装置本体6に配設された制御部16、再循環検出部17及び表示部18とを有して構成されている。なお、第1の実施形態と同様の構成要素には、同一の符号を付し、それらの詳細な説明を省略する。
Next, a blood purification apparatus according to a third embodiment of the present invention will be described.
The blood purification device according to this embodiment purifies a patient's blood while circulating it extracorporeally, and is applied to a hemodialysis device used in hemodialysis treatment. As shown in Fig. 1, this hemodialysis device comprises a blood circuit 1 connected to a dialyzer 2 as a blood purification unit, a dialysis device main body 6 that supplies dialysate to the dialyzer 2 while removing water from the dialyzer 2, and a control unit 16, a recirculation detection unit 17, and a display unit 18 disposed in the dialysis device main body 6. Note that the same components as those in the first embodiment are designated by the same reference numerals, and detailed descriptions thereof will be omitted.

 再循環検出部17は、第1の実施形態と同様、第1検出部5a及び第2検出部5bで検出された血液濃度に基づいて、図4に示すように、横軸を経過時間(積算流量又は時間)及び縦軸を血液濃度(ヘマトクリット値)とした局所的な濃度変化α、βを示すグラフを作成するとともに、その血液濃度の変化を所定周期(例えば0.1s周期)で監視している。これにより、特有のピークP1が形成された局所的な濃度変化αの開始時点R1及び終了時点R2と、特有のピークP2が形成された局所的な濃度変化βの開始時点W1及び終了時点W2とを検出することができ、局所的な濃度変化αの面積S1と局所的な濃度変化βの面積S2とを精度よく演算し得るようになっている。 As in the first embodiment, the recirculation detection unit 17 creates a graph showing local concentration changes α and β, with the horizontal axis representing elapsed time (cumulative flow rate or time) and the vertical axis representing blood concentration (hematocrit value), as shown in Figure 4, based on the blood concentration detected by the first detection unit 5a and the second detection unit 5b, and monitors the blood concentration changes at a predetermined interval (e.g., 0.1 second interval). This makes it possible to detect the start time R1 and end time R2 of the local concentration change α at which the characteristic peak P1 is formed, and the start time W1 and end time W2 of the local concentration change β at which the characteristic peak P2 is formed, and to accurately calculate the area S1 of the local concentration change α and the area S2 of the local concentration change β.

 ここで、本実施形態に係る再循環検出部17は、図11に示すように、特有のピークP1が検出された後における局所的な濃度変化αの時間経過または血液の積算流量に伴う変化量を検出し、変化量が減少から増加に変化した時点を局所的な濃度変化αの終了時点R2として特定するよう構成されている。具体的には、再循環検出部17は、局所的な濃度変化αにおける特有のピークP1が検出された後のグラフの血液濃度の値を逐次(本実施形態においては周期毎に)算出し、算出されたグラフの血液濃度の値が最小値となる時点を終了時点R2として特定する。 Here, as shown in FIG. 11, the recirculation detection unit 17 according to this embodiment is configured to detect the amount of change in the local concentration change α over time or with the cumulative blood flow rate after the characteristic peak P1 is detected, and identify the point at which the amount of change changes from a decrease to an increase as the end point R2 of the local concentration change α. Specifically, the recirculation detection unit 17 sequentially (every cycle in this embodiment) calculates the value of the blood concentration on the graph after the characteristic peak P1 in the local concentration change α is detected, and identifies the point at which the calculated value of the blood concentration on the graph reaches a minimum as the end point R2.

 例えば、再循環検出部17は、局所的な濃度変化αにおける特有のピークP1が検出された後のグラフの血液濃度の値を周期毎に逐次算出し、その算出されたグラフの血液濃度の値が減少から増加に変化した位置を最小値として特定することができる。また、血液濃度の値が減少から増加に変化せず一定の値が続いた場合(グラフが平坦な状態の場合)、血液濃度の値が最初に一定の値に変化した位置を最小値とすることができる。さらに、血液濃度の値が減少し続けた場合、測定終端位置を最小値とすることができる。なお、グラフ中の波形のピーク(局所的な濃度変化αの特有のピークP1及び局所的な濃度変化βの特有のピークP2)は、各波形の最大値を算出することにより求めることができる。 For example, the recirculation detection unit 17 can sequentially calculate the blood concentration value on the graph for each period after the characteristic peak P1 in the local concentration change α is detected, and identify the position where the calculated blood concentration value on the graph changes from a decrease to an increase as the minimum value. Furthermore, if the blood concentration value does not change from a decrease to an increase and remains constant (if the graph is flat), the position where the blood concentration value first changes to a constant value can be identified as the minimum value. Furthermore, if the blood concentration value continues to decrease, the measurement end position can be identified as the minimum value. The peaks of the waveforms in the graph (the characteristic peak P1 of the local concentration change α and the characteristic peak P2 of the local concentration change β) can be found by calculating the maximum value of each waveform.

 しかるに、本実施形態においては、再循環検出部17により再循環血液を検出して再循環血液の比率を算出する工程は、血液浄化治療が行われる治療工程とは別の測定工程にて行われる。かかる測定工程時においては、制御部16は、制御対象のポンプ(複式ポンプC、血液ポンプ3、除水ポンプ10、加圧ポンプ11、補液ポンプ15、薬液注入ポンプ等)を駆動するためのパラメータを血液浄化治療が行われる治療工程時とは異なる測定用パラメータに変更して制御するようになっている。かかる測定工程については、第1の実施形態と同様であり、図5のフローチャートに基づいて説明する。 However, in this embodiment, the process of detecting recirculated blood using the recirculation detection unit 17 and calculating the proportion of recirculated blood is performed in a measurement process separate from the treatment process in which blood purification treatment is performed. During this measurement process, the control unit 16 controls the pumps to be controlled (duplex pump C, blood pump 3, water removal pump 10, pressure pump 11, fluid replacement pump 15, drug injection pump, etc.) by changing the parameters for driving them to measurement parameters that are different from those used during the treatment process in which blood purification treatment is performed. This measurement process is the same as in the first embodiment, and will be described based on the flowchart in Figure 5.

 まず、操作者による切替入力部SW1の操作を条件として測定工程が開始されると、S1にて制御部16によって制御対象のポンプを測定用パラメータに一時変更し、その測定パラメータに基づいて当該ポンプを駆動させた後、S2にて第1検出部5a及び第2検出部5bで検出される血液濃度が安定状態になるまで待機する。かかる測定用パラメータは、ポンプ(制御対象のポンプ)の駆動速度を治療工程時より低下または停止させるパラメータから成る。そして、第1検出部5a及び第2検出部5bで検出される血液濃度が安定状態になった後、操作者による指示入力部SW2の操作を条件として、S3に進み、電磁弁14を操作して大気開放ライン13を開放させることにより、特有のピークP1、P2が形成された局所的な濃度変化を付与する。 First, when the measurement process is initiated upon operation of the switch input unit SW1 by the operator, the control unit 16 temporarily changes the parameters of the pump to be controlled to measurement parameters in S1 and drives the pump based on those measurement parameters. Then, in S2, the system waits until the blood concentration detected by the first detection unit 5a and the second detection unit 5b stabilizes. These measurement parameters consist of parameters that slow or stop the drive speed of the pump (the pump to be controlled) from that during the treatment process. Then, upon operation of the instruction input unit SW2 by the operator, the system proceeds to S3, where the solenoid valve 14 is operated to open the atmosphere vent line 13, thereby creating localized concentration changes that form characteristic peaks P1 and P2.

 その後、S4に進み、第1検出部5aで検出された局所的な濃度変化αと、第2検出部5bで検出された局所的な濃度変化βとに基づいて、再循環検出部17が再循環血液を検出し、再循環血液の比率(再循環率)を算出する。そして、再循環血液の検出及び再循環血液の比率(再循環率)が算出された後、操作者による切替入力部SW1の操作を条件として、S5に進み、制御部16によって測定パラメータから治療用パラメータに復帰する。これにより、測定工程が終了し、治療用パラメータに基づいて血液浄化治療を行わせることができる。 Then, the process proceeds to S4, where the recirculation detection unit 17 detects recirculated blood and calculates the proportion of recirculated blood (recirculation rate) based on the local concentration change α detected by the first detection unit 5a and the local concentration change β detected by the second detection unit 5b. After the recirculated blood has been detected and the proportion of recirculated blood (recirculation rate) calculated, the process proceeds to S5, where the control unit 16 reverts from measurement parameters to treatment parameters, provided that the operator operates the switch input unit SW1. This completes the measurement process, and blood purification treatment can be performed based on the treatment parameters.

 次に、上記測定工程の測定S4について、再循環検出部17による具体的制御内容を図10のフローチャートに基づいて説明する。
 図5のS3により局所的な濃度変化が付与された後、Sc1にて再循環検出部17による局所的な濃度変化αの特有のピークP1の検出が行われ、当該特有のピークP1が検出されると、Sc2にて特有のピークP1の検出後における濃度の最小値を検出する。かかる最小値は、局所的な濃度変化αにおける特有のピークP1が検出された後のグラフの血液濃度の値を逐次算出して求めることができ、算出されたグラフの血液濃度の値が最小値となる時点を終了時点R2として特定することができる。
Next, the specific control contents of the recirculation detection unit 17 in the measurement S4 of the measurement process will be described with reference to the flowchart of FIG.
5, after the local concentration change is given in S3, the recirculation detection unit 17 detects the characteristic peak P1 of the local concentration change α in Sc1. When the characteristic peak P1 is detected, the minimum value of the concentration after the detection of the characteristic peak P1 is detected in Sc2. This minimum value can be obtained by sequentially calculating the value of the blood concentration on the graph after the characteristic peak P1 of the local concentration change α is detected, and the point at which the calculated value of the blood concentration on the graph reaches the minimum can be identified as the end point R2.

 その後、Sc3に進み、特有のピークP1が形成された局所的な濃度変化αの開始時点R1及び終了時点R2と、特有のピークP2が形成された局所的な濃度変化βの開始時点W1及び終了時点W2とに基づいて、図4で示す面積S1及び面積S2を求め、これら面積S1、S2の割合から再循環血液の割合である再循環率(Rrec(%))を求めることができる。 Then, proceed to Sc3, and based on the start time R1 and end time R2 of the local concentration change α at which the characteristic peak P1 is formed, and the start time W1 and end time W2 of the local concentration change β at which the characteristic peak P2 is formed, the areas S1 and S2 shown in Figure 4 are calculated, and the recirculation rate (Rrec (%)), which is the proportion of recirculated blood, can be calculated from the ratio of these areas S1 and S2.

 本実施形態によれば、再循環検出部17は、局所的な濃度変化αにおける特有のピークP1が検出された後のグラフの血液濃度の値を逐次算出し、算出されたグラフの血液濃度の値が最小値となる時点を終了時点R2として特定するので、特有のピークP1後の血液濃度の最小値を求めて、少なくとも局所的な濃度変化αの終了時点R2を精度よく検出することにより再循環血液の比率を高精度に算出することができる。 In this embodiment, the recirculation detection unit 17 sequentially calculates the blood concentration value on the graph after the characteristic peak P1 in the local concentration change α is detected, and identifies the point at which the calculated blood concentration value on the graph reaches its minimum as the end point R2.Therefore, by determining the minimum value of the blood concentration after the characteristic peak P1 and accurately detecting at least the end point R2 of the local concentration change α, the proportion of recirculated blood can be calculated with high precision.

 次に、本発明に係る第4の実施形態の血液浄化装置について説明する。
 本実施形態に係る血液浄化装置は、患者の血液を体外循環させつつ浄化するためのもので、血液透析治療で使用される血液透析装置に適用されたものである。かかる血液透析装置は、図1に示すように、血液浄化部としてのダイアライザ2が接続された血液回路1と、ダイアライザ2に透析液を供給しつつ除水する透析装置本体6と、透析装置本体6に配設された制御部16、再循環検出部17及び表示部18とを有して構成されている。なお、第1の実施形態と同様の構成要素には、同一の符号を付し、それらの詳細な説明を省略する。
Next, a blood purification apparatus according to a fourth embodiment of the present invention will be described.
The blood purification device according to this embodiment purifies a patient's blood while circulating it extracorporeally, and is applied to a hemodialysis device used in hemodialysis treatment. As shown in Fig. 1, this hemodialysis device comprises a blood circuit 1 connected to a dialyzer 2 as a blood purification unit, a dialysis device main body 6 that supplies dialysate to the dialyzer 2 while removing water from the dialyzer 2, and a control unit 16, a recirculation detection unit 17, and a display unit 18 disposed in the dialysis device main body 6. Note that the same components as those in the first embodiment are designated by the same reference numerals, and detailed descriptions thereof will be omitted.

 再循環検出部17は、第1の実施形態と同様、第1検出部5a及び第2検出部5bで検出された血液濃度に基づいて、図4に示すように、横軸を経過時間(積算流量又は時間)及び縦軸を血液濃度(ヘマトクリット値)とした局所的な濃度変化α、βを示すグラフを作成するとともに、その血液濃度の変化を所定周期(例えば0.1s周期)で監視している。これにより、特有のピークP1が形成された局所的な濃度変化αの開始時点R1及び終了時点R2と、特有のピークP2が形成された局所的な濃度変化βの開始時点W1及び終了時点W2とを検出することができ、局所的な濃度変化αの面積S1と局所的な濃度変化βの面積S2とを精度よく演算し得るようになっている。 As in the first embodiment, the recirculation detection unit 17 creates a graph showing local concentration changes α and β, with the horizontal axis representing elapsed time (cumulative flow rate or time) and the vertical axis representing blood concentration (hematocrit value), as shown in Figure 4, based on the blood concentration detected by the first detection unit 5a and the second detection unit 5b, and monitors the blood concentration changes at a predetermined interval (e.g., 0.1 second interval). This makes it possible to detect the start time R1 and end time R2 of the local concentration change α at which the characteristic peak P1 is formed, and the start time W1 and end time W2 of the local concentration change β at which the characteristic peak P2 is formed, and to accurately calculate the area S1 of the local concentration change α and the area S2 of the local concentration change β.

 ここで、本実施形態に係る再循環検出部17は、例えばマイコン等で構成されたものであり、第1検出部5aで検出された局所的な濃度変化βと第2検出部5bで検出された局所的な濃度変化αとに基づいて、静脈側血液回路1bから患者に戻された血液が再び動脈側血液回路1aに導かれて流れる再循環血液を検出し、再循環血液の比率(再循環率)を算出可能なものである。 The recirculation detection unit 17 in this embodiment is configured, for example, with a microcomputer, and is capable of detecting recirculated blood, which is blood returned to the patient from the venous blood circuit 1b and then guided back into the arterial blood circuit 1a, based on the local concentration change β detected by the first detection unit 5a and the local concentration change α detected by the second detection unit 5b, and calculating the proportion of recirculated blood (recirculation rate).

 特に、本実施形態に係る再循環検出部17は、図13に示すように、局所的な濃度変化αにおける特有のピークP1が検出された後のグラフの傾き(同図中の2点間を結ぶ直線mの傾き)を逐次(本実施形態においては周期毎に)算出し、算出されたグラフの傾きが水平(傾きが0)となる時点を終了時点R2として特定するよう構成されている。なお、グラフ中の波形のピーク(局所的な濃度変化αの特有のピークP1及び局所的な濃度変化βの特有のピークP2)は、第1の実施形態と同様、各波形の最大値を算出することにより求めることができる。また、所定周期毎の傾きは、周期内の曲線に対して最小二乗法等の演算方法を用いて求めることができる。 In particular, the recirculation detection unit 17 according to this embodiment is configured to sequentially (for each cycle in this embodiment) calculate the slope of the graph (the slope of the line m connecting two points in the figure) after the characteristic peak P1 in the local concentration change α is detected, as shown in FIG. 13, and identify the point at which the calculated slope of the graph becomes horizontal (slope is 0) as the end point R2. Note that the waveform peaks in the graph (the characteristic peak P1 of the local concentration change α and the characteristic peak P2 of the local concentration change β) can be found by calculating the maximum value of each waveform, as in the first embodiment. Furthermore, the slope for each predetermined cycle can be found using a calculation method such as the least squares method on the curve within the cycle.

 しかるに、本実施形態においては、第1の実施形態と同様、再循環検出部17により再循環血液を検出して再循環血液の比率を算出する工程は、血液浄化治療が行われる治療工程とは別の測定工程にて行われる。かかる測定工程時においては、制御部16は、制御対象のポンプ(複式ポンプC、血液ポンプ3、除水ポンプ10、加圧ポンプ11、補液ポンプ15、薬液注入ポンプ等)を駆動するためのパラメータを血液浄化治療が行われる治療工程時とは異なる測定用パラメータに変更して制御するようになっている。かかる測定工程については、第1の実施形態において、図5のフローチャートに基づいて説明した通りである。 However, in this embodiment, as in the first embodiment, the process of detecting recirculated blood using the recirculation detection unit 17 and calculating the proportion of recirculated blood is performed in a measurement process separate from the treatment process in which blood purification treatment is performed. During this measurement process, the control unit 16 controls the pumps to be controlled (duplex pump C, blood pump 3, water removal pump 10, pressure pump 11, fluid replacement pump 15, drug injection pump, etc.) by changing the parameters for driving them to measurement parameters that are different from those used during the treatment process in which blood purification treatment is performed. This measurement process is as described in the first embodiment based on the flowchart in Figure 5.

 次に、上記測定工程の測定S4(図5参照)について、再循環検出部17による具体的制御内容を図12のフローチャートに基づいて説明する。
 図5のS3により局所的な濃度変化が付与された後、Sd1にて再循環検出部17による局所的な濃度変化αの特定のピークP1を検出する。そして、特定のピークP1が検出された後、Sd2に進み、その特定のピークP1が検出された後のグラフの傾きを逐次算出し、算出されたグラフの傾きが水平(傾きが0)となる時点を終了時点R2として特定する。
Next, the specific control contents by the recirculation detection unit 17 in measurement S4 (see FIG. 5) of the measurement step will be described with reference to the flowchart of FIG.
5, after the local concentration change is given in S3, in Sd1, a specific peak P1 of the local concentration change α is detected by the recirculation detection unit 17. Then, after the specific peak P1 is detected, the process proceeds to Sd2, where the slope of the graph after the specific peak P1 is detected is calculated sequentially, and the point in time when the calculated slope of the graph becomes horizontal (slope is 0) is identified as the end point R2.

 その後、Sd3に進み、特有のピークP1が形成された局所的な濃度変化αの開始時点R1及び終了時点R2と、特有のピークP2が形成された局所的な濃度変化βの開始時点W1及び終了時点W2とに基づいて、図4で示す面積S1及び面積S2を求め、これら面積S1、S2の割合から再循環血液の割合である再循環率(Rrec(%))を求めることができる。 Then, proceed to Sd3, and based on the start time R1 and end time R2 of the local concentration change α at which the characteristic peak P1 is formed, and the start time W1 and end time W2 of the local concentration change β at which the characteristic peak P2 is formed, the areas S1 and S2 shown in Figure 4 are calculated, and the recirculation rate (Rrec (%)), which is the proportion of recirculated blood, can be calculated from the ratio of these areas S1 and S2.

 本実施形態によれば、再循環検出部17は、局所的な濃度変化αにおける特有のピークP1が検出された後のグラフの傾きを逐次算出し、算出されたグラフの傾きが水平となる時点を終了時点R2として特定するので、特有のピークP1後のグラフの傾きを求めて、少なくとも局所的な濃度変化αの終了時点R2を精度よく検出することにより再循環血液の比率を高精度に算出することができる。 In this embodiment, the recirculation detection unit 17 sequentially calculates the slope of the graph after the characteristic peak P1 in the local concentration change α is detected, and identifies the point in time at which the calculated slope of the graph becomes horizontal as the end point R2.Therefore, by determining the slope of the graph after the characteristic peak P1 and accurately detecting at least the end point R2 of the local concentration change α, the proportion of recirculated blood can be calculated with high accuracy.

 次に、本発明に係る第5の実施形態の血液浄化装置について説明する。
 本実施形態に係る血液浄化装置は、患者の血液を体外循環させつつ浄化するためのもので、血液透析治療で使用される血液透析装置に適用されたものである。かかる血液透析装置は、図1に示すように、血液浄化部としてのダイアライザ2が接続された血液回路1と、ダイアライザ2に透析液を供給しつつ除水する透析装置本体6と、透析装置本体6に配設された制御部16、再循環検出部17及び表示部18とを有して構成されている。なお、第1の実施形態と同様の構成要素には、同一の符号を付し、それらの詳細な説明を省略する。
Next, a blood purification apparatus according to a fifth embodiment of the present invention will be described.
The blood purification device according to this embodiment purifies a patient's blood while circulating it extracorporeally, and is applied to a hemodialysis device used in hemodialysis treatment. As shown in Fig. 1, this hemodialysis device comprises a blood circuit 1 connected to a dialyzer 2 as a blood purification unit, a dialysis device main body 6 that supplies dialysate to the dialyzer 2 while removing water from the dialyzer 2, and a control unit 16, a recirculation detection unit 17, and a display unit 18 disposed in the dialysis device main body 6. Note that the same components as those in the first embodiment are designated by the same reference numerals, and detailed descriptions thereof will be omitted.

 再循環検出部17は、第1の実施形態と同様、第1検出部5a及び第2検出部5bで検出された血液濃度に基づいて、図5に示すように、横軸を経過時間(積算流量又は時間)及び縦軸を血液濃度(ヘマトクリット値)とした局所的な濃度変化α、βを示すグラフを作成するとともに、その血液濃度の変化を所定周期(例えば0.1s周期)で監視している。これにより、特有のピークP1が形成された局所的な濃度変化αの開始時点R1及び終了時点R2と、特有のピークP2が形成された局所的な濃度変化βの開始時点W1及び終了時点W2とを検出することができ、局所的な濃度変化αの面積S1と局所的な濃度変化βの面積S2とを精度よく演算し得るようになっている。 As in the first embodiment, the recirculation detection unit 17 creates a graph showing local concentration changes α and β, with the horizontal axis representing elapsed time (cumulative flow rate or time) and the vertical axis representing blood concentration (hematocrit value), as shown in Figure 5, based on the blood concentration detected by the first detection unit 5a and the second detection unit 5b, and monitors the changes in blood concentration at a predetermined interval (e.g., 0.1 second interval). This makes it possible to detect the start time R1 and end time R2 of the local concentration change α at which the characteristic peak P1 is formed, and the start time W1 and end time W2 of the local concentration change β at which the characteristic peak P2 is formed, and to accurately calculate the area S1 of the local concentration change α and the area S2 of the local concentration change β.

 ここで、本実施形態に係る再循環検出部17は、例えばマイコン等で構成されたものであり、第1検出部5aで検出された局所的な濃度変化βと第2検出部5bで検出された局所的な濃度変化αとに基づいて、静脈側血液回路1bから患者に戻された血液が再び動脈側血液回路1aに導かれて流れる再循環血液を検出し、再循環血液の比率(再循環率)を算出可能なものである。 The recirculation detection unit 17 in this embodiment is configured, for example, with a microcomputer, and is capable of detecting recirculated blood, which is blood returned to the patient from the venous blood circuit 1b and then guided back into the arterial blood circuit 1a, based on the local concentration change β detected by the first detection unit 5a and the local concentration change α detected by the second detection unit 5b, and calculating the proportion of recirculated blood (recirculation rate).

 特に、本実施形態に係る再循環検出部17は、図15に示すように、局所的な濃度変化αにおける特有のピークP1が検出された後のグラフの面積(同図中の2点間内の領域の面積Sn)を逐次(本実施形態においては周期毎に)算出し、算出されたグラフの面積の変化率が低下した時点を終了時点R2として特定するよう構成されている。なお、グラフ中の波形のピーク(局所的な濃度変化αの特有のピークP1及び局所的な濃度変化βの特有のピークP2)は、第1の実施形態と同様、各波形の最大値を算出することにより求めることができる。また、所定周期毎の面積は、周期内の曲線に対して積分法等の演算方法を用いて求めることができる。 In particular, the recirculation detection unit 17 according to this embodiment is configured to sequentially (for each cycle in this embodiment) calculate the area of the graph (the area Sn of the region between two points in the figure) after the characteristic peak P1 of the local concentration change α is detected, as shown in FIG. 15, and identify the point at which the rate of change of the calculated area of the graph decreases as the end point R2. Note that the waveform peaks in the graph (the characteristic peak P1 of the local concentration change α and the characteristic peak P2 of the local concentration change β) can be found by calculating the maximum value of each waveform, as in the first embodiment. Furthermore, the area for each predetermined cycle can be found using an arithmetic method such as integration on the curve within the cycle.

 しかるに、本実施形態においては、第1の実施形態と同様、再循環検出部17により再循環血液を検出して再循環血液の比率を算出する工程は、血液浄化治療が行われる治療工程とは別の測定工程にて行われる。かかる測定工程時においては、制御部16は、制御対象のポンプ(複式ポンプC、血液ポンプ3、除水ポンプ10、加圧ポンプ11、補液ポンプ15等)を駆動するためのパラメータを血液浄化治療が行われる治療工程時とは異なる測定用パラメータに変更して制御するようになっている。かかる測定工程については、第1の実施形態において、図5のフローチャートに基づいて説明した通りである。 However, in this embodiment, as in the first embodiment, the process of detecting recirculated blood using the recirculation detection unit 17 and calculating the proportion of recirculated blood is performed in a measurement process separate from the treatment process in which blood purification treatment is performed. During this measurement process, the control unit 16 controls the pumps to be controlled (duplex pump C, blood pump 3, water removal pump 10, pressure pump 11, fluid replacement pump 15, etc.) by changing the parameters for driving them to measurement parameters that are different from those used during the treatment process in which blood purification treatment is performed. This measurement process is as described in the first embodiment based on the flowchart in Figure 5.

 次に、上記測定工程の測定S4(図5参照)について、再循環検出部17による具体的制御内容を図14のフローチャートに基づいて説明する。
 図5のS3により局所的な濃度変化が付与された後、Se1にて再循環検出部17による局所的な濃度変化αの特定のピークP1を検出する。そして、特定のピークP1が検出された後、Se2に進み、その特定のピークP1が検出された後のグラフの面積を逐次算出し、算出されたグラフの面積の変化率が低下した時点を終了時点R2として特定する。
Next, the specific control contents of the recirculation detection unit 17 in measurement S4 (see FIG. 5) of the measurement step will be described with reference to the flowchart of FIG.
5, after the local concentration change is given in S3, Se1 detects a specific peak P1 of the local concentration change α by the recirculation detection unit 17. Then, after the specific peak P1 is detected, the process proceeds to Se2, where the area of the graph after the specific peak P1 is detected is calculated sequentially, and the point in time at which the rate of change of the calculated area of the graph decreases is identified as the end point R2.

 その後、Se3に進み、特有のピークP1が形成された局所的な濃度変化αの開始時点R1及び終了時点R2と、特有のピークP2が形成された局所的な濃度変化βの開始時点W1及び終了時点W2とに基づいて、図5で示す面積S1及び面積S2を求め、これら面積S1、S2の割合から再循環血液の割合である再循環率(Rrec(%))を求めることができる。 Then, proceed to Se3, and based on the start time R1 and end time R2 of the local concentration change α at which the characteristic peak P1 is formed, and the start time W1 and end time W2 of the local concentration change β at which the characteristic peak P2 is formed, the areas S1 and S2 shown in Figure 5 are calculated, and the recirculation rate (Rrec (%)), which is the proportion of recirculated blood, can be calculated from the ratio of these areas S1 and S2.

 本実施形態によれば、再循環検出部17は、局所的な濃度変化αにおける特有のピークP1が検出された後のグラフの面積を逐次算出し、算出されたグラフの面積の変化率が低下した時点を終了時点R2として特定するので、特有のピークP1後のグラフの面積を求めて、少なくとも局所的な濃度変化αの終了時点R2を精度よく検出することにより再循環血液の比率を高精度に算出することができる。 In this embodiment, the recirculation detection unit 17 sequentially calculates the area of the graph after the characteristic peak P1 in the local concentration change α is detected, and identifies the point at which the rate of change in the calculated graph area decreases as the end point R2.Therefore, by determining the area of the graph after the characteristic peak P1 and accurately detecting at least the end point R2 of the local concentration change α, the proportion of recirculated blood can be calculated with high accuracy.

 以上、本実施形態について説明したが、本発明はこれらに限定されるものではなく、例えば特性変化付与部は、特有のピークが形成された局所的な濃度変化を付与し得るものであれば、大気開放ライン13及び電磁弁14で構成されるものに限られず、他の手段としてもよい。また、本実施形態に係る特性変化付与部は、除水により血液を濃縮することにより血液濃度を局所的に変化させているが、例えば補液等の置換液(透析液)を血液回路に導入することにより、血液を希釈して血液濃度を局所的に変化させるようにしてもよい。 Although the present embodiment has been described above, the present invention is not limited to this. For example, the characteristic change imparting unit is not limited to being composed of the air vent line 13 and solenoid valve 14, and other means may be used as long as it is capable of imparting a local concentration change with a unique peak. Furthermore, while the characteristic change imparting unit in this embodiment locally changes the blood concentration by concentrating the blood through water removal, it is also possible to locally change the blood concentration by diluting the blood, for example, by introducing a replacement fluid (dialysis fluid) such as replacement fluid into the blood circuit.

 また、特有のピークが形成された血液濃度の変化を検出し得るものであれば、ヘマトクリットセンサ以外(例えばヘモグロビン濃度を検出するセンサやタンパク質等の濃度を検出するセンサなど)にて第1検出部5a及び第2検出部5bを構成してもよい。さらに、第1検出部5a及び第2検出部5bは、それぞれ動脈側血液回路1a及び静脈側血液回路1bであれば何れの部位に配設するようにしてもよい。 Furthermore, the first detector 5a and the second detector 5b may be configured with something other than a hematocrit sensor (for example, a sensor that detects hemoglobin concentration or a sensor that detects the concentration of proteins, etc.) as long as it can detect changes in blood concentration that form a unique peak. Furthermore, the first detector 5a and the second detector 5b may be disposed at any location on the arterial blood circuit 1a and the venous blood circuit 1b, respectively.

 またさらに、本実施形態に係る血液の特性変化は、血液の濃度変化とされているが、血液の温度変化等、他の特性変化であってもよい。例えば超音波を使用するものであって、血流にマーカ(生理食塩水やマイクロバブル)を注入し、超音波プローブを用いて希釈カーブを測定するとともに、血液回路内での血流の変化をリアルタイムで捉えることで、再循環率を定量化可能なものであってもよい。 Furthermore, although the change in blood characteristics in this embodiment is a change in blood concentration, it may also be a change in other characteristics, such as a change in blood temperature. For example, ultrasound may be used to inject a marker (saline or microbubbles) into the blood flow, measure the dilution curve using an ultrasound probe, and capture changes in blood flow within the blood circuit in real time, making it possible to quantify the recirculation rate.

 また、色素を動脈側血液回路に注入し、静脈側血液回路で吸光度を測定することで再循環を評価するもの、血液回路に冷却された生理食塩水を注入し、血液温度の変化を測定するものであって、温度センサを動脈側血液回路と静脈側血液回路に配置して温度の変化率から再循環率を算出するものであってもよい。さらに、電気インピーダンスを使用するものであって、血液回路内の血液の電気インピーダンス変化を測定し、血液の流れの変化を解析するものとし、生理食塩水の導電率を利用して再循環によるインピーダンス変化を計算するもの、或いは光学を使用するものであって、赤外分光法(NIRS)を用いて血液の酸素飽和度やヘモグロビン濃度の変化を測定するものとし、動脈側血液回路と静脈側血液回路のデータを比較して再循環の影響を評価するものであってもよい。 Furthermore, it may be a method for evaluating recirculation by injecting a dye into the arterial blood circuit and measuring absorbance in the venous blood circuit, or a method for injecting cooled saline into the blood circuit and measuring changes in blood temperature, with temperature sensors placed in the arterial and venous blood circuits to calculate the recirculation rate from the rate of temperature change. Furthermore, it may be a method that uses electrical impedance to measure changes in the electrical impedance of the blood in the blood circuit and analyze changes in blood flow, and calculates impedance changes due to recirculation using the conductivity of the saline, or a method that uses optics to measure changes in blood oxygen saturation and hemoglobin concentration using near-infrared spectroscopy (NIRS), and evaluates the effects of recirculation by comparing data from the arterial and venous blood circuits.

 本発明の第1の実施の態様は、動脈側血液回路1a及び静脈側血液回路1bを有した血液回路1を通して患者の血液を体外循環させ、血液を浄化する血液浄化装置であって、血液回路1を体外循環する血液の濃度変化に特有のピークが形成された局所的な濃度変化を付与し得る特性変化付与部(大気開放ライン13及び電磁弁14)と、動脈側血液回路1a及び静脈側血液回路1bにそれぞれ取り付けられ、特性変化付与部で付与された局所的な濃度変化α、βを検出する第1検出部5a及び第2検出部5bと、第1検出部5aで検出された局所的な濃度変化βと第2検出部5bで検出された局所的な濃度変化αとに基づいて、静脈側血液回路1bから患者に戻された血液が再び動脈側血液回路1aに導かれて流れる再循環血液を検出し、再循環血液の比率を算出する再循環検出部17とを具備し、再循環検出部17は、局所的な濃度変化が検出される直前に検出されるノイズ波形γを検出するとともに、ノイズ波形γに基づいて局所的な濃度変化αの開始時点R1を特定するものである。これにより、ノイズ波形γを利用して、少なくとも局所的な濃度変化αの開始時点R1を精度よく検出することにより再循環血液の比率を高精度に算出することができる。 The first embodiment of the present invention is a blood purification device that circulates a patient's blood extracorporeally through a blood circuit 1 having an arterial blood circuit 1a and a venous blood circuit 1b, and purifies the blood. The device comprises a characteristic change imparting unit (air vent line 13 and solenoid valve 14) that can impart local concentration changes that form peaks specific to the concentration changes of the blood circulating extracorporeally through the blood circuit 1, and a first detection unit 5a and a second detection unit 5b that are attached to the arterial blood circuit 1a and the venous blood circuit 1b, respectively, and that detect the local concentration changes α and β imparted by the characteristic change imparting unit. The system includes a second detection unit (5b), and a recirculation detection unit (17) that detects recirculated blood, which is blood returned to the patient from the venous blood circuit (1b) and re-circulated into the arterial blood circuit (1a) based on the local concentration change (β) detected by the first detection unit (5a) and the local concentration change (α) detected by the second detection unit (5b), and calculates the proportion of recirculated blood. The recirculation detection unit (17) detects a noise waveform (γ) detected just before the local concentration change is detected, and identifies the start time (R1) of the local concentration change (α) based on the noise waveform (γ). This allows the proportion of recirculated blood to be calculated with high accuracy by accurately detecting at least the start time (R1) of the local concentration change (α) using the noise waveform (γ).

 本発明の第2の実施の態様は、第1の実施の態様において、再循環検出部17は、ノイズ波形γのピークP3を検出した後、濃度変化が減少から増加に変化した時点を局所的な濃度変化αの開始時点R1として特定するものである。これにより、ノイズ波形γを利用して、精度よく局所的な濃度変化αの開始時点R1を特定することができる。 In a second embodiment of the present invention, the recirculation detection unit 17 in the first embodiment detects peak P3 of the noise waveform γ and then identifies the point in time when the concentration change changes from a decrease to an increase as the start point R1 of the local concentration change α. This makes it possible to accurately identify the start point R1 of the local concentration change α using the noise waveform γ.

 本発明の第3の実施の態様は、第2の実施の態様において、再循環検出部17は、時間経過または血液の積算流量に伴う濃度変化を示すグラフにおける所定周期毎の傾きまたは面積を逐次検出するとともに、その検出された傾きの変化または面積の変化に基づいて濃度変化の減少及び増加を検出するものである。これにより、ノイズ波形γを利用して、円滑かつ精度よく局所的な濃度変化αの開始時点R1を特定することができる。 A third embodiment of the present invention is a second embodiment in which the recirculation detection unit 17 sequentially detects the slope or area for each predetermined period in a graph showing concentration changes over time or with the cumulative blood flow rate, and detects decreases and increases in concentration changes based on the detected changes in slope or area. This makes it possible to smoothly and accurately identify the start point R1 of a local concentration change α using the noise waveform γ.

 本発明の第4の実施の態様は、動脈側血液回路1a及び静脈側血液回路1bを有した血液回路1を通して患者の血液を体外循環させ、血液を浄化する血液浄化装置であって、血液回路1を体外循環する血液の濃度変化に特有のピークが形成された局所的な濃度変化を付与し得る特性変化付与部(大気開放ライン13及び電磁弁14)と、動脈側血液回路1a及び静脈側血液回路1bにそれぞれ取り付けられ、特性変化付与部で付与された局所的な濃度変化α、βを検出する第1検出部5a及び第2検出部5bと、第1検出部5aで検出された局所的な濃度変化βと第2検出部5bで検出された局所的な濃度変化αとに基づいて、静脈側血液回路1bから患者に戻された血液が再び動脈側血液回路1aに導かれて流れる再循環血液を検出し、再循環血液の比率を算出する再循環検出部17とを具備し、再循環検出部17は、局所的な濃度変化αにおける特定のピークP1が検出された時点を基準として、局所的な濃度変化αの検出開始時に遡って順次検索し、濃度変化が減少から増加に変化した時点を局所的な濃度変化の開始時点R1として特定するものである。これにより、特定のピークP1を利用して、少なくとも局所的な濃度変化αの開始時点R1を精度よく検出することにより再循環血液の比率を高精度に算出することができる。 A fourth embodiment of the present invention is a blood purification device that circulates a patient's blood extracorporeally through a blood circuit 1 having an arterial blood circuit 1a and a venous blood circuit 1b, and purifies the blood. The device comprises a characteristic change imparting unit (air vent line 13 and solenoid valve 14) that can impart local concentration changes that form peaks specific to the concentration changes in the blood circulating extracorporeally through the blood circuit 1, a first detection unit 5a and a second detection unit 5b that are attached to the arterial blood circuit 1a and the venous blood circuit 1b, respectively, and that detect the local concentration changes α and β imparted by the characteristic change imparting unit, and The system is equipped with a recirculation detection unit 17 that detects recirculated blood, which is blood returned to the patient from the venous blood circuit 1b and then introduced back into the arterial blood circuit 1a, based on the detected local concentration change β and the local concentration change α detected by the second detection unit 5b, and calculates the proportion of recirculated blood.The recirculation detection unit 17 uses the time when a specific peak P1 in the local concentration change α is detected as a reference point and sequentially searches back to the start of detection of the local concentration change α, identifying the time when the concentration change changes from a decrease to an increase as the start time R1 of the local concentration change.This allows the proportion of recirculated blood to be calculated with high accuracy by accurately detecting at least the start time R1 of the local concentration change α using the specific peak P1.

 本発明の第5の実施の態様は、第4の実施の態様において、再循環検出部17は、時間経過または血液の積算流量に伴う濃度変化を示すグラフにおける所定周期毎の傾きまたは面積を逐次検出するとともに、その検出された傾きの変化または面積の変化に基づいて濃度変化の減少及び増加を検出するものである。これにより、特定のピークP1を利用して、円滑かつ精度よく局所的な濃度変化αの開始時点R1を特定することができる。 In a fifth embodiment of the present invention, in the fourth embodiment, the recirculation detection unit 17 sequentially detects the slope or area for each predetermined period in a graph showing concentration changes over time or with the cumulative blood flow rate, and detects decreases and increases in concentration changes based on the detected changes in slope or area. This makes it possible to smoothly and accurately identify the start point R1 of a local concentration change α by utilizing a specific peak P1.

 本発明の第6の実施の態様は、動脈側血液回路1a及び静脈側血液回路1bを有した血液回路1を通して患者の血液を体外循環させ、血液を浄化する血液浄化装置であって、血液回路1を体外循環する血液の濃度変化に特有のピークが形成された局所的な濃度変化を付与し得る特性変化付与部(大気開放ライン13及び電磁弁14)と、動脈側血液回路1a及び静脈側血液回路1bにそれぞれ取り付けられ、特性変化付与部で付与された局所的な濃度変化α、βを検出する第1検出部5a及び第2検出部5bと、第1検出部5aで検出された局所的な濃度変化βと第2検出部5bで検出された局所的な濃度変化αとに基づいて、静脈側血液回路1bから患者に戻された血液が再び動脈側血液回路1aに導かれて流れる再循環血液を検出し、再循環血液の比率を算出する再循環検出部17とを具備した血液浄化装置であって、再循環検出部17は、特有のピークP1が検出された後における局所的な濃度変化αの時間経過または血液の積算流量に伴う変化量を検出し、変化量が減少から増加に変化した時点を局所的な濃度変化αの終了時点R2として特定するものである。これにより、少なくとも局所的な濃度変化αの終了時点R2を精度よく検出することにより再循環血液の比率を高精度に算出することができる。 A sixth embodiment of the present invention is a blood purification device that circulates a patient's blood extracorporeally through a blood circuit 1 having an arterial blood circuit 1a and a venous blood circuit 1b, and purifies the blood. The device comprises a characteristic change imparting unit (air vent line 13 and solenoid valve 14) that can impart local concentration changes that form peaks specific to the concentration changes in the blood circulating extracorporeally through the blood circuit 1, a first detection unit 5a and a second detection unit 5b that are attached to the arterial blood circuit 1a and the venous blood circuit 1b, respectively, and that detect the local concentration changes α and β imparted by the characteristic change imparting unit, and a second detection unit 5b that detects the local concentration changes α and β imparted by the characteristic change imparting unit. This blood purification device is equipped with a recirculation detection unit 17 that detects recirculated blood, where blood returned to the patient from the venous blood circuit 1b is guided back into the arterial blood circuit 1a and flows, based on the local concentration change β detected by the first detection unit 5b and the local concentration change α detected by the second detection unit 5b, and calculates the proportion of recirculated blood.The recirculation detection unit 17 detects the amount of change in the local concentration change α over time or with the integrated blood flow rate after the detection of the characteristic peak P1, and identifies the point at which the amount of change changes from a decrease to an increase as the end point R2 of the local concentration change α.This allows the proportion of recirculated blood to be calculated with high accuracy by accurately detecting at least the end point R2 of the local concentration change α.

 本発明の第7の実施の態様は、第6の実施の態様において、再循環検出部17は、局所的な濃度変化αにおける特有のピークP1が検出された後のグラフの血液濃度の値を逐次算出し、算出されたグラフの血液濃度の値が最小値となる時点を終了時点R2として特定するものである。これにより、特有のピークP1が検出された後の最小値を求めて、精度よく局所的な濃度変化αの終了時点R2を特定することができる。 In a seventh embodiment of the present invention, in the sixth embodiment, the recirculation detection unit 17 sequentially calculates the blood concentration value on the graph after a characteristic peak P1 in the local concentration change α is detected, and identifies the point in time at which the calculated blood concentration value on the graph reaches its minimum as the end point R2. This makes it possible to determine the minimum value after the characteristic peak P1 is detected, and accurately identify the end point R2 of the local concentration change α.

 本発明の第8の実施の態様は、第6の実施の態様において、再循環検出部17は、局所的な濃度変化αにおける特有のピークP1が検出された後のグラフの傾きを逐次算出し、算出されたグラフの傾きが水平となる時点を終了時点R2として特定するものである。これにより、特有のピークP1が検出された後のグラフの傾きを求めて、精度よく局所的な濃度変化αの終了時点R2を特定することができる。 In an eighth embodiment of the present invention, in the sixth embodiment, the recirculation detection unit 17 sequentially calculates the slope of the graph after a characteristic peak P1 in the local concentration change α is detected, and identifies the point in time at which the calculated slope of the graph becomes horizontal as the end point R2. This makes it possible to determine the slope of the graph after the characteristic peak P1 is detected, and accurately identify the end point R2 of the local concentration change α.

 本発明の第9の実施の態様は、第6の実施の態様において、再循環検出部17は、局所的な濃度変化αにおける特有のピークP1が検出された後のグラフの面積を逐次算出し、算出されたグラフの面積の変化率が低下した時点を終了時点R2として特定するものである。これにより、特有のピークP1が検出された後のグラフの面積を求めて、精度よく局所的な濃度変化αの終了時点R2を特定することができる。 A ninth embodiment of the present invention is a sixth embodiment in which the recirculation detection unit 17 sequentially calculates the area of the graph after a characteristic peak P1 in the local concentration change α is detected, and identifies the point in time at which the rate of change in the calculated graph area decreases as the end point R2. This makes it possible to determine the area of the graph after the characteristic peak P1 is detected, and accurately identify the end point R2 of the local concentration change α.

 本発明の第10の実施の態様は、第1、4、6の何れか1つの実施の態様において、再循環検出部は、血液浄化治療が行われる治療工程とは別の測定工程において、再循環血液を検出して再循環血液の比率を算出する。 A tenth embodiment of the present invention is any one of the first, fourth, and sixth embodiments, in which the recirculation detection unit detects recirculated blood and calculates the proportion of recirculated blood in a measurement process separate from the treatment process in which blood purification treatment is performed.

 本発明の第11の実施の態様は、第10の実施の態様において、操作者が入力操作可能な切替入力部又は指示入力部を具備するとともに、前記測定工程は、前記切替入力部又は前記指示入力部の入力操作を条件として所定の工程が実行される。 An eleventh embodiment of the present invention is the tenth embodiment, further comprising a switching input unit or instruction input unit that can be operated by an operator, and the measurement process is performed as a predetermined step, conditional on input operation of the switching input unit or instruction input unit.

 本発明の第12の実施の態様は、第1、4、6の何れか1つの実施の態様において、血液の特性は、血液の濃度である。これにより、血液の濃度変化に基づいて再循環血液を検出し、再循環血液の比率を算出することができる。 A twelfth embodiment of the present invention is any one of the first, fourth, and sixth embodiments, in which the blood characteristic is blood concentration. This makes it possible to detect recirculating blood based on changes in blood concentration and calculate the proportion of recirculating blood.

 本発明と同様の趣旨であれば、外観形状が異なるもの或いは他の機能が付加されたもの等にも適用することができる。 As long as the purpose is the same as that of the present invention, it can also be applied to products with different external shapes or with added functions.

 1 血液回路
 1a 動脈側血液回路
 1b 静脈側血液回路
 2 ダイアライザ(血液浄化部)
 3 血液ポンプ
 4a、4b エアトラップチャンバ
 5a 第1検出部
 5b 第2検出部
 6 透析装置本体
 7 透析液導入ライン
 8 透析液排出ライン
 9 バイパスライン
 10 除水ポンプ
 11 加圧ポンプ
 12 気泡分離チャンバ
 13 大気開放ライン
 14 電磁弁
 15 補液ポンプ
 16 制御部
 17 再循環検出部
 18 表示部
 C 複式ポンプ
 La 供給ライン
 La1 前補液用供給ライン
 La2 後補液用供給ライン
 SW1 切替入力部
 SW2 指示入力部
1 Blood circuit 1a Arterial blood circuit 1b Venous blood circuit 2 Dialyzer (blood purification section)
3 Blood pump 4a, 4b Air trap chamber 5a First detection unit 5b Second detection unit 6 Dialysis device main body 7 Dialysis fluid introduction line 8 Dialysis fluid discharge line 9 Bypass line 10 Water removal pump 11 Pressurizing pump 12 Air bubble separation chamber 13 Atmospheric release line 14 Solenoid valve 15 Infusion fluid pump 16 Control unit 17 Recirculation detection unit 18 Display unit C Duplex pump La Supply line La1 Pre-infusion fluid supply line La2 Post-infusion fluid supply line SW1 Switching input unit SW2 Instruction input unit

Claims (12)

 動脈側血液回路及び静脈側血液回路を有した血液回路を通して患者の血液を体外循環させ、血液を浄化する血液浄化装置であって、
 前記血液回路を体外循環する血液の特性変化に特有のピークが形成された局所的な特性変化を付与し得る特性変化付与部と、
 前記動脈側血液回路及び静脈側血液回路にそれぞれ取り付けられ、前記特性変化付与部で付与された局所的な特性変化を検出する第1検出部及び第2検出部と、
 前記第1検出部で検出された局所的な特性変化と前記第2検出部で検出された局所的な特性変化とに基づいて、前記静脈側血液回路から患者に戻された血液が再び前記動脈側血液回路に導かれて流れる再循環血液を検出し、前記再循環血液の比率を算出する再循環検出部と、
を具備し、
 前記再循環検出部は、前記局所的な特性変化が検出される直前に検出されるノイズ波形を検出するとともに、前記ノイズ波形に基づいて前記局所的な特性変化の開始時点を特定する血液浄化装置。
A blood purification device that purifies a patient's blood by extracorporeally circulating the blood through a blood circuit having an arterial blood circuit and a venous blood circuit,
a characteristic change applying unit that applies a local characteristic change in which a peak specific to the characteristic change of blood circulating extracorporeally through the blood circuit is formed;
a first detection unit and a second detection unit attached to the arterial blood circuit and the venous blood circuit, respectively, for detecting the local characteristic change imparted by the characteristic change imparting unit;
a recirculation detection unit that detects recirculated blood, which is blood returned to a patient from the venous blood circuit and then guided back into the arterial blood circuit, based on the local characteristic change detected by the first detection unit and the local characteristic change detected by the second detection unit, and calculates a ratio of the recirculated blood;
Equipped with
The blood purification device wherein the recirculation detection unit detects a noise waveform detected immediately before the local characteristic change is detected, and identifies the start time of the local characteristic change based on the noise waveform.
 前記再循環検出部は、前記ノイズ波形のピークを検出した後、前記特性変化が減少から増加に変化した時点を前記局所的な特性変化の開始時点として特定する請求項1記載の血液浄化装置。 The blood purification device of claim 1, wherein the recirculation detection unit, after detecting a peak in the noise waveform, identifies the point at which the characteristic change changes from a decrease to an increase as the start point of the local characteristic change.  前記再循環検出部は、時間経過または血液の積算流量に伴う前記特性変化を示すグラフにおける所定周期毎の傾きまたは面積を逐次検出するとともに、その検出された前記傾きの変化または面積の変化に基づいて前記特性変化の減少及び増加を検出する請求項2記載の血液浄化装置。 The blood purification device of claim 2, wherein the recirculation detection unit sequentially detects the slope or area for each predetermined period in a graph showing the change in the characteristic over time or with the cumulative blood flow rate, and detects decreases and increases in the change in the characteristic based on the detected changes in the slope or area.  動脈側血液回路及び静脈側血液回路を有した血液回路を通して患者の血液を体外循環させ、血液を浄化する血液浄化装置であって、
 前記血液回路を体外循環する血液の特性変化に特有のピークが形成された局所的な特性変化を付与し得る特性変化付与部と、
 前記動脈側血液回路及び静脈側血液回路にそれぞれ取り付けられ、前記特性変化付与部で付与された局所的な特性変化を検出する第1検出部及び第2検出部と、
 前記第1検出部で検出された局所的な特性変化と前記第2検出部で検出された局所的な特性変化とに基づいて、前記静脈側血液回路から患者に戻された血液が再び前記動脈側血液回路に導かれて流れる再循環血液を検出し、前記再循環血液の比率を算出する再循環検出部と、
を具備し、
 前記再循環検出部は、前記局所的な特性変化における特定のピークが検出された時点を基準として、前記局所的な特性変化の検出開始時に遡って順次検索し、前記特性変化が減少から増加に変化した時点を前記局所的な特性変化の開始時点として特定する血液浄化装置。
A blood purification device that purifies a patient's blood by extracorporeally circulating the blood through a blood circuit having an arterial blood circuit and a venous blood circuit,
a characteristic change applying unit that applies a local characteristic change in which a peak specific to the characteristic change of blood circulating extracorporeally through the blood circuit is formed;
a first detection unit and a second detection unit attached to the arterial blood circuit and the venous blood circuit, respectively, for detecting the local characteristic change imparted by the characteristic change imparting unit;
a recirculation detection unit that detects recirculated blood, which is blood returned to a patient from the venous blood circuit and then guided back into the arterial blood circuit, based on the local characteristic change detected by the first detection unit and the local characteristic change detected by the second detection unit, and calculates a ratio of the recirculated blood;
Equipped with
The recirculation detection unit sequentially searches back to the start of detection of the local characteristic change, using the time when a specific peak in the local characteristic change is detected as a reference point, and identifies the time when the characteristic change changes from decreasing to increasing as the start of the local characteristic change.
 前記再循環検出部は、時間経過または血液の積算流量に伴う前記特性変化を示すグラフにおける所定周期毎の傾きまたは面積を逐次検出するとともに、その検出された前記傾きの変化または面積の変化に基づいて前記特性変化の減少及び増加を検出する請求項4記載の血液浄化装置。 The blood purification device of claim 4, wherein the recirculation detection unit sequentially detects the slope or area for each predetermined period in a graph showing the change in the characteristic over time or with the cumulative blood flow rate, and detects decreases and increases in the change in the characteristic based on the detected changes in the slope or area.  動脈側血液回路及び静脈側血液回路を有した血液回路を通して患者の血液を体外循環させ、血液を浄化する血液浄化装置であって、
 前記血液回路を体外循環する血液の特性変化に特有のピークが形成された局所的な特性変化を付与し得る特性変化付与部と、
 前記動脈側血液回路及び静脈側血液回路にそれぞれ取り付けられ、前記特性変化付与部で付与された局所的な特性変化を検出する第1検出部及び第2検出部と、
 前記第1検出部で検出された局所的な特性変化と前記第2検出部で検出された局所的な特性変化とに基づいて、前記静脈側血液回路から患者に戻された血液が再び前記動脈側血液回路に導かれて流れる再循環血液を検出し、前記再循環血液の比率を算出する再循環検出部と、
を具備し、
 前記再循環検出部は、前記特有のピークが検出された後における前記局所的な特性変化の時間経過または血液の積算流量に伴う変化量を検出し、前記変化量が減少から増加に変化した時点を前記局所的な特性変化の終了時点として特定する血液浄化装置。
A blood purification device that purifies a patient's blood by extracorporeally circulating the blood through a blood circuit having an arterial blood circuit and a venous blood circuit,
a characteristic change applying unit that applies a local characteristic change in which a peak specific to the characteristic change of blood circulating extracorporeally through the blood circuit is formed;
a first detection unit and a second detection unit attached to the arterial blood circuit and the venous blood circuit, respectively, for detecting the local characteristic change imparted by the characteristic change imparting unit;
a recirculation detection unit that detects recirculated blood, which is blood returned to a patient from the venous blood circuit and then guided back into the arterial blood circuit, based on the local characteristic change detected by the first detection unit and the local characteristic change detected by the second detection unit, and calculates a ratio of the recirculated blood;
Equipped with
The recirculation detection unit detects the amount of change in the local characteristic change over time or with the cumulative blood flow rate after the specific peak is detected, and identifies the point at which the amount of change changes from a decrease to an increase as the end point of the local characteristic change.
 前記再循環検出部は、前記局所的な特性変化における特有のピークが検出された後のグラフの血液特性の値を逐次算出し、算出された前記グラフの血液特性の値が最小値となる時点を前記終了時点として特定する請求項6記載の血液浄化装置。 The blood purification device of claim 6, wherein the recirculation detection unit sequentially calculates the value of the blood characteristic on the graph after a specific peak in the local characteristic change is detected, and identifies the point at which the calculated value of the blood characteristic on the graph reaches a minimum as the end point.  前記再循環検出部は、前記局所的な特性変化における特有のピークが検出された後のグラフの傾きを逐次算出し、算出された前記グラフの傾きが水平となる時点を前記終了時点として特定する請求項6記載の血液浄化装置。 The blood purification device of claim 6, wherein the recirculation detection unit sequentially calculates the slope of the graph after a specific peak in the local characteristic change is detected, and identifies the end point as the point at which the calculated slope of the graph becomes horizontal.  前記再循環検出部は、前記局所的な特性変化における特有のピークが検出された後のグラフの面積を逐次算出し、算出された前記グラフの面積の変化率が低下した時点を前記終了時点として特定する請求項6記載の血液浄化装置。 The blood purification device of claim 6, wherein the recirculation detection unit sequentially calculates the area of the graph after a specific peak in the local characteristic change is detected, and identifies the point at which the rate of change in the calculated area of the graph decreases as the end point.  前記再循環検出部は、血液浄化治療が行われる治療工程とは別の測定工程において、再循環血液を検出して再循環血液の比率を算出する請求項1、4、6の何れか1つに記載の血液浄化装置。 A blood purification device as described in any one of claims 1, 4, and 6, wherein the recirculation detection unit detects recirculated blood and calculates the proportion of recirculated blood in a measurement process separate from the treatment process in which blood purification treatment is performed.  操作者が入力操作可能な切替入力部又は指示入力部を具備するとともに、前記測定工程は、前記切替入力部又は前記指示入力部の入力操作を条件として所定の工程が実行される請求項10記載の血液浄化装置。 The blood purification device of claim 10, further comprising a switching input unit or an instruction input unit that can be operated by an operator, and wherein the measurement process is performed in accordance with input operation of the switching input unit or the instruction input unit.  前記血液の特性は、血液の濃度である請求項1、4、6の何れか1つに記載の血液浄化装置。 A blood purification device according to any one of claims 1, 4, and 6, wherein the blood characteristic is blood concentration.
PCT/JP2025/004809 2024-02-14 2025-02-13 Blood purification device Pending WO2025173750A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2024-020716 2024-02-14
JP2024020716 2024-02-14
JP2024-020717 2024-02-14
JP2024020717 2024-02-14

Publications (1)

Publication Number Publication Date
WO2025173750A1 true WO2025173750A1 (en) 2025-08-21

Family

ID=96773067

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2025/004809 Pending WO2025173750A1 (en) 2024-02-14 2025-02-13 Blood purification device

Country Status (1)

Country Link
WO (1) WO2025173750A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626827A (en) * 1988-08-17 1997-05-06 The Mennen Company Basic aluminum antiperspirant active materials having enhanced activity, antiperspirant active compositions containing such materials, and methods for preparation of such materials and compositions
JP2004329747A (en) * 2003-05-12 2004-11-25 Toray Medical Co Ltd Shunt recycling rate calculation system of hemodialysis device
JP2010068927A (en) * 2008-09-17 2010-04-02 Nikkiso Co Ltd Blood purifying apparatus
JP2019187888A (en) * 2018-04-26 2019-10-31 日機装株式会社 Blood purification device
JP2021500539A (en) * 2017-10-18 2021-01-07 ヴェン バイオサイエンシズ コーポレーション Identification and use of biological parameters for diagnostic and therapeutic monitoring

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626827A (en) * 1988-08-17 1997-05-06 The Mennen Company Basic aluminum antiperspirant active materials having enhanced activity, antiperspirant active compositions containing such materials, and methods for preparation of such materials and compositions
JP2004329747A (en) * 2003-05-12 2004-11-25 Toray Medical Co Ltd Shunt recycling rate calculation system of hemodialysis device
JP2010068927A (en) * 2008-09-17 2010-04-02 Nikkiso Co Ltd Blood purifying apparatus
JP2021500539A (en) * 2017-10-18 2021-01-07 ヴェン バイオサイエンシズ コーポレーション Identification and use of biological parameters for diagnostic and therapeutic monitoring
JP2019187888A (en) * 2018-04-26 2019-10-31 日機装株式会社 Blood purification device

Similar Documents

Publication Publication Date Title
JP4868772B2 (en) Blood purification equipment
JP4573860B2 (en) Blood purification equipment
JP5548001B2 (en) Blood purification equipment
KR102220982B1 (en) Device and method for detecting the recirculation during an extracorporeal blood treatment
JP4925159B2 (en) Blood purification equipment
JP7061509B2 (en) Blood purification device
KR100498628B1 (en) System and method for noninvasive hemodynamic measurements in hemodialysis shunts
US20080103427A1 (en) Blood purification device
JP5222706B2 (en) Blood purification apparatus and blood flow calculation method thereof
WO2025173750A1 (en) Blood purification device
WO2025173752A1 (en) Blood purification apparatus
CN100548392C (en) blood purification device
JP7569212B2 (en) Blood Purification Device
WO2025173751A1 (en) Blood purification device
JP4442825B2 (en) Blood purification equipment
CN112312940A (en) Blood purification device and method for obtaining plasma flow rate of blood purification device
WO2025211286A1 (en) Blood purification device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 25754621

Country of ref document: EP

Kind code of ref document: A1